Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3005411	s-scc-ag	ug/l (ug/l)	451	840	0.00%
3005411	s-scc-ag	— (—)	342	480	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

371

125

17.66

317.73

2.2

1.1

4.23

2.24

ug/l

0.70

229

Malignant neoplasm, wide definition for exclusion

369

125

17.56

315.37

2.2

1.1

4.26

2.24

ug/l

0.71

227

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

369

125

17.56

315.35

2.2

1.1

4.26

2.24

ug/l

0.71

227

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

390

118.84

307.65

2.5

1.0

4.11

2.18

ug/l

0.72

266

malignant neoplasm of female genital organs

293

42.20

307.65

2.7

1.1

4.94

2.05

ug/l

0.98

195

Malignant neoplasm of cervix uteri

134

146.40

268.08

3.3

2.2

6.39

2.70

ug/l

—

Any event in cancer register

338

192

10.50

227.98

2.2

1.3

4.62

1.97

ug/l

0.94

204

119

Melanocytic naevi

141

36.52

226.81

1.0

1.64

2.40

ug/l

0.52

Malignant neoplasm

315

197

9.53

200.74

2.3

1.4

4.76

2.04

ug/l

0.87

189

121

Neoplasms

213

23.87

186.25

1.9

1.2

3.35

3.03

ug/l

0.08

126

In situ neoplasms

122

20.20

154.79

1.6

1.1

1.62

2.65

ug/l

0.50

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

159

15.59

143.83

1.2

1.1

1.83

2.72

ug/l

0.54

Melanocytic naevi, other sites/unspecified

105

19.37

133.90

1.0

1.9

1.80

1.78

ug/l

0.01

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

102

14.52

105.10

2.2

1.0

9.98

3.05

ug/l

0.84

Benign neoplasms

142

13.20

104.76

1.4

1.2

2.36

2.76

ug/l

0.19

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

120

13.63

102.72

1.3

1.1

1.81

2.84

ug/l

0.53

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

120

13.38

101.58

1.3

1.1

1.80

2.78

ug/l

0.51

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

111

12.53

90.71

1.3

1.1

1.87

2.84

ug/l

0.49

Melanocytic naevi

141

213

6.68

88.69

1.0

2.0

1.64

3.79

ug/l

0.95

123

Malignant melanoma, excluding all cancers (controls excluding all cancers)

23.53

87.63

1.1

1.0

1.58

1.43

ug/l

0.22

Actinic keratosis

135

186

6.94

86.26

1.0

1.8

1.69

2.55

ug/l

2.07

114

Skin changes due to chronic exposure to nonionizing radiation

135

191

6.73

83.79

1.0

1.9

1.69

2.54

ug/l

2.10

117

138

202

6.47

82.32

1.2

1.9

1.74

2.50

ug/l

1.87

124

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

27.75

81.12

1.1

1.0

1.65

1.33

ug/l

—

HSIL lesion of the cervix uteri, vagina or vulva

116

162

7.24

78.53

1.7

2.1

7.74

2.71

ug/l

0.59

All dysplastic lesions of the cervix uteri, vagina or vulva

130

240

5.42

66.14

1.6

2.2

7.13

2.46

ug/l

0.61

147

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

23.03

66.13

2.0

1.0

14.82

1.56

ug/l

—

Melanocytic naevi of trunk

28.91

64.18

1.0

1.51

1.38

ug/l

—

Carcinoma in situ of cervix uteri

29.59

61.60

1.8

1.0

1.71

2.06

ug/l

—

Other disorders of skin and subcutaneous tissue

176

418

3.87

57.82

1.3

2.0

1.83

3.15

ug/l

1.20

100

254

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

22.46

54.44

1.6

1.0

2.51

1.58

ug/l

0.93

In situ neoplasms

122

270

4.54

50.80

1.6

1.8

1.62

3.50

ug/l

1.00

147

Malignant neoplasm of skin

151

285

4.00

48.85

1.2

1.9

1.85

2.58

ug/l

1.90

171

Other benign neoplasms of skin

8.92

46.56

1.0

2.12

3.08

ug/l

0.39

Abnormal findings in secretions and smears from cervix uteri vagina vulva

156

332

3.71

46.13

2.0

2.1

2.13

4.43

ug/l

0.75

105

201

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

159

373

3.49

43.63

2.0

2.13

4.18

ug/l

0.72

105

222

HSIL lesion of the cervix uteri

148

5.59

43.29

1.6

2.2

7.02

4.41

ug/l

0.18

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

11.33

42.19

2.6

1.0

19.01

1.54

ug/l

0.96

Other medical care

115

273

4.13

42.18

2.7

1.6

6.96

2.22

ug/l

0.69

143

Other noninflammatory disorders of vulva and perineum

7.84

39.98

1.6

2.0

6.15

2.60

ug/l

0.38

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

13.77

39.91

3.2

1.0

12.27

1.42

ug/l

0.92

Other skin changes

108

6.25

39.74

1.1

2.2

1.56

2.20

ug/l

1.45

Basal cell carcinoma

124

271

3.66

36.27

1.3

1.9

1.79

2.69

ug/l

2.40

159

GASTRO-related operations

157

230

3.43

35.65

2.2

1.3

3.98

2.06

ug/l

0.53

141

Any gastric operation

157

230

3.43

35.65

2.2

1.3

3.98

2.06

ug/l

0.53

141

All dysplastic lesions of the vulva

10.23

35.47

1.7

1.8

8.54

1.97

ug/l

0.49

Seborrhoeic keratosis

150

5.03

35.38

1.0

1.7

1.43

2.72

ug/l

2.88

Dysplasia of cervi uteri

148

4.68

35.30

1.6

2.3

6.65

2.66

ug/l

0.37

Basal cell carcinoma, including avohilmo

125

278

3.55

34.95

1.2

1.9

1.78

2.65

ug/l

2.29

164

All dysplastic lesions of the cervix uteri

223

4.10

33.27

1.5

2.1

6.46

3.87

ug/l

0.21

132

Carcinoma in situ of other and unspecified genital organs

17.62

32.57

1.8

1.9

2.06

2.20

ug/l

—

Malignant melanoma

5.70

30.30

1.1

2.0

1.66

2.11

ug/l

0.76

Complications of procedures, not elsewhere classified

160

522

2.65

28.16

2.1

1.7

2.05

3.36

ug/l

0.75

101

318

Other malignant neoplasms of skin (=non-melanoma skin cancer)

107

254

3.33

27.36

1.3

1.9

1.85

2.71

ug/l

2.04

151

Benign neoplasms

175

369

2.65

27.31

1.4

2.1

2.23

4.40

ug/l

0.89

246

Complications of surgical and medical care, not elsewhere classified

184

535

2.47

26.81

2.0

1.7

3.45

3.36

ug/l

0.02

114

325

Benign neoplasm of colon, rectum, anus and anal canal

5.59

26.62

1.3

1.1

1.73

2.67

ug/l

0.56

Lichen sclerosus et atrophicus

5.84

26.62

1.9

1.8

2.12

2.59

ug/l

0.28

Symptoms and signs involving the skin and subcutaneous tissue

142

528

2.68

26.37

1.5

1.9

1.70

2.92

ug/l

1.64

332

Benign neoplasm: Colon

5.81

25.03

1.3

1.1

1.81

2.86

ug/l

0.56

Malignant melanoma of skin

5.76

24.11

1.1

1.8

1.87

2.07

ug/l

0.22

Other epidermal thickening

12.16

23.87

1.1

1.9

2.09

3.15

ug/l

—

Follow-up examination after treatment for malignant neoplasms

6.01

22.92

1.6

1.8

2.32

2.55

ug/l

0.09

Melanocytic naevi of trunk

5.41

22.10

1.0

2.1

1.51

1.91

ug/l

0.54

Oxycodone

219

3.41

21.66

3.3

1.4

11.04

2.07

ug/l

0.95

116

Ulcer of vagina/vulva

12.62

21.25

2.1

2.4

1.93

2.14

ug/l

—

Atrophic disorders of skin

114

4.50

21.21

1.9

2.1

2.10

2.62

ug/l

0.33

Benign neoplasm: Skin of other and unspecified parts of face

13.39

21.09

1.1

1.0

1.10

1.57

ug/l

—

Diseases of the skin and subcutaneous tissue

168

352

2.40

20.89

1.6

2.0

3.58

3.85

ug/l

0.04

223

Carcinoma in situ of cervix uteri

5.23

20.30

1.8

1.9

1.71

2.09

ug/l

0.40

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

5.58

19.42

1.1

1.0

2.68

2.97

ug/l

0.08

Examination and observation for other reasons

114

263

2.64

18.31

2.0

1.8

2.28

4.39

ug/l

0.63

173

Benign neoplasm of ovary

7.76

17.40

1.5

1.0

3.23

1.49

ug/l

0.80

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

4.36

17.39

1.4

1.1

12.59

2.42

ug/l

0.44

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

4.36

17.39

1.4

1.1

12.59

2.42

ug/l

0.44

Benign lipomatous neoplasm

5.62

17.23

1.8

1.0

1.56

2.14

ug/l

0.46

Leiomyoma of uterus

4.33

17.22

1.6

1.1

3.28

2.45

ug/l

0.28

Persons encountering health services for specific procedures and health care

177

532

2.06

16.59

2.4

1.6

5.25

2.62

ug/l

0.49

114

313

Localized swelling, mass and lump of skin and subcutaneous tissue

225

2.99

15.41

1.8

1.70

2.34

ug/l

1.57

126

Artificial opening status

7.85

15.30

1.2

2.0

2.07

1.75

ug/l

0.18

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

4.80

15.18

1.2

1.1

18.22

2.67

ug/l

0.45

Complications of medical and surgical care

123

537

2.18

14.57

2.2

1.7

4.28

3.30

ug/l

0.18

322

Any reimbursement code in KELA

100

198

2.53

14.10

2.0

1.5

1.86

1.94

ug/l

0.09

119

Colorectal cancer, excluding all cancers (controls excluding all cancers)

5.77

13.66

1.0

2.18

ug/l

0.00

Benign neoplasm of other and ill-defined parts of digestive system

7.16

13.54

1.1

1.0

1.96

1.43

ug/l

0.48

Hydronephrosis

4.37

13.31

3.8

1.6

20.50

2.12

ug/l

0.84

Non-invasive ventilation

158

3.16

13.27

2.1

1.8

1.70

3.87

ug/l

0.68

Benign neoplasm: Stomach

10.81

12.86

1.1

1.0

1.92

1.41

ug/l

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

100

453

2.20

12.38

2.1

1.7

2.04

2.24

ug/l

0.37

270

Melanocytic naevi of upper limb, including shoulder

10.15

12.26

1.0

2.0

1.07

2.18

ug/l

—

Other bacterial diseases

138

502

1.90

10.80

2.4

1.6

6.22

2.70

ug/l

0.52

296

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

6.55

10.62

1.1

1.0

2.62

1.41

ug/l

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

434

2.12

10.46

2.2

1.7

2.00

2.92

ug/l

0.73

250

Postmenopausal bleeding

134

2.63

10.12

2.3

2.1

2.38

2.89

ug/l

0.43

Benign neoplasm: Rectum, anus and anal canal

5.82

10.05

1.0

1.38

1.42

ug/l

—

Primary_lymphoid and hematopoietic malignant neoplasms

5.00

9.54

1.5

1.0

2.02

1.56

ug/l

—

Benign neoplasm: Rectum

6.17

9.45

1.0

1.38

1.39

ug/l

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

6.68

8.89

1.6

1.0

1.79

1.56

ug/l

—

Dermatitis

491

1.96

8.85

1.3

1.9

4.74

2.19

ug/l

0.47

296

Benign neoplasm: Ascending colon

7.24

8.84

1.2

1.0

2.71

1.33

ug/l

—

Corns and callosities

4.78

8.58

1.0

2.0

2.16

2.71

ug/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

6.38

8.52

2.5

1.0

1.22

1.30

ug/l

—

Other and unspecified dermatitis

413

2.01

8.30

1.2

2.0

5.27

2.10

ug/l

0.51

250

Fever of other and unknown origin

365

2.03

8.14

2.5

1.8

2.26

3.03

ug/l

0.48

224

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

114

2.51

8.10

1.9

1.58

4.62

ug/l

0.72

Benign neoplasm of other and unspecified endocrine glands

6.20

7.71

2.1

1.0

3.48

1.49

ug/l

—

Melanocytic naevi of lower limb, including hip

5.04

7.67

1.0

1.8

1.64

1.91

ug/l

—

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

4.18

7.65

1.5

1.1

1.30

3.10

ug/l

—

Parasetamol

109

300

1.86

7.53

1.8

1.6

2.12

2.04

ug/l

0.09

177

L04AD Calcineurin inhibitors

3.66

7.45

1.0

1.6

2.24

1.79

ug/l

0.37

Opioids

140

434

1.69

7.25

2.5

1.5

4.59

2.05

ug/l

0.74

258

First line medication for Crohn's disease

154

516

1.63

6.95

1.8

2.27

2.83

ug/l

0.43

312

Other metabolic disorders

113

2.84

6.93

3.9

1.6

2.72

1.96

ug/l

0.45

Hypertrophic scar

4.71

6.69

1.5

1.7

1.97

2.34

ug/l

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

110

2.83

6.67

4.0

1.6

2.78

1.98

ug/l

0.46

Viral warts

3.26

6.54

1.1

1.8

2.24

1.97

ug/l

0.18

Renal tubulo-interstitial diseases

118

537

1.69

6.54

2.2

1.7

9.28

2.18

ug/l

0.96

323

Dermatitis and eczema

145

591

1.61

6.52

1.2

1.9

4.64

3.03

ug/l

0.36

360

Benign neoplasm of other and unspecified female genital organs

3.95

6.44

1.1

2.3

1.72

2.52

ug/l

0.66

Benign neoplasm: Colon, unspecified

4.31

6.43

1.2

1.0

1.51

2.25

ug/l

0.42

Tramadol

106

392

1.74

6.36

1.9

1.5

2.89

2.02

ug/l

0.78

232

Anaemias

3.15

6.30

2.1

1.6

12.46

1.60

ug/l

0.57

Hypertrophic disorders of skin

4.23

6.28

1.6

1.83

2.06

ug/l

—

Genitourinary diseases

170

2.04

6.24

1.9

1.5

1.75

2.34

ug/l

0.82

Malignant neoplasm of corpus uteri

3.01

6.22

1.3

2.2

2.94

2.59

ug/l

0.19

Benign neoplasm: Sigmoid colon

5.01

6.22

1.5

1.0

1.93

1.42

ug/l

—

Noninflammatory disorders of female genital tract

190

1.96

6.07

2.3

2.2

2.15

2.85

ug/l

0.84

126

Depression medications

2.71

5.98

1.9

1.6

2.31

1.63

ug/l

0.65

Other disorders of pigmentation

4.85

5.98

1.0

2.3

1.43

2.92

ug/l

—

General symptoms and signs

150

484

1.55

5.58

1.9

1.8

2.38

2.79

ug/l

0.26

302

Transplanted organ and tissue status

3.40

5.57

1.0

1.8

2.22

2.04

ug/l

—

Squamous cell neoplasms and carcinomas of the skin

3.14

5.45

1.0

1.7

1.98

2.75

ug/l

0.70

Other benign neoplasms of skin

300

1.94

5.36

1.0

1.9

2.12

3.20

ug/l

0.48

166

Benign neoplasm of breast

4.62

5.25

1.2

1.0

1.26

2.42

ug/l

—

Other special examinations and investigations of persons without complaint or reported diagnosis

263

1.73

5.13

1.3

1.8

1.85

4.39

ug/l

0.83

173

ILD medications: azathioprine

103

2.63

5.13

1.1

1.9

1.59

2.02

ug/l

0.51

Symptoms and signs involving the digestive system and abdomen

135

439

1.54

4.91

2.0

1.6

1.95

4.06

ug/l

1.02

271

Melanoma in situ

4.61

4.78

1.0

2.2

1.28

2.01

ug/l

—

Azathioprine

107

2.53

4.78

1.1

1.9

1.59

1.88

ug/l

0.32

Acute renal failure

115

2.44

4.61

1.4

1.5

5.43

2.30

ug/l

0.67

Hypothyroidism (congenital or acquired)

2.60

4.58

1.8

1.6

10.86

1.63

ug/l

0.46

Dermatophytosis

2.72

4.50

1.1

1.8

1.49

2.09

ug/l

0.80

Bacterial infection, other or unspecified

321

1.77

4.42

2.6

1.6

9.77

2.19

ug/l

0.63

175

Hypertensive diseases (excluding secondary)

271

1.70

4.38

1.5

1.8

6.09

4.02

ug/l

0.22

156

Abdominal and pelvic pain

130

439

1.49

4.12

2.1

1.6

1.97

4.06

ug/l

1.00

271

Seborrhoeic dermatitis

2.99

4.12

1.0

1.8

1.75

1.65

ug/l

—

Inflammatory diseases of female pelvic organs

101

494

1.54

4.07

1.8

2.0

2.07

3.91

ug/l

0.98

311

Erysipelas

336

1.71

3.97

2.4

1.7

1.89

2.10

ug/l

0.44

187

Cardiovascular diseases (excluding rheumatic etc)

331

1.59

3.97

1.6

1.8

5.33

3.58

ug/l

0.22

199

Other abnormal uterine and vaginal bleeding

137

2.03

3.97

2.2

2.0

3.51

2.71

ug/l

0.34

Congenital malformations of genital organs

2.66

3.94

1.1

1.9

1.74

1.91

ug/l

—

Persons encountering health services for examination and investigation

263

1.62

3.90

1.4

1.8

1.93

4.39

ug/l

0.79

173

Lichen planus

101

2.38

3.80

1.8

1.18

2.32

ug/l

3.28

Hypothyroidism, levothyroxine purchases

2.41

3.74

1.8

1.6

11.49

1.63

ug/l

0.46

Hypothyroidism and >3 levothyroxin purchases

2.41

3.74

1.8

1.6

11.49

1.63

ug/l

0.46

Agranulocytosis

2.42

3.63

3.0

1.7

2.68

1.87

ug/l

0.73

Benign neoplasm: Skin of other and unspecified parts of face

2.54

3.62

1.1

1.8

1.10

2.22

ug/l

—

Pain (limb, back, neck, head abdominally)

304

1.55

3.62

1.6

1.7

2.07

2.92

ug/l

0.45

193

N06DA Anticholinesterases

161

0.25

3.57

2.6

1.6

1.32

2.61

ug/l

—

Use of anticholinesterases

161

0.25

3.57

2.6

1.6

1.32

2.61

ug/l

—

Hypertensive diseases

105

398

1.49

3.52

1.6

1.9

4.89

3.54

ug/l

0.21

230

Hypertension

105

398

1.49

3.52

1.6

1.9

4.89

3.54

ug/l

0.21

230

Certain infectious and parasitic diseases

129

450

1.44

3.47

2.1

1.7

1.95

2.79

ug/l

0.70

271

Hypertension, essential

101

386

1.49

3.41

1.9

1.8

5.04

3.55

ug/l

0.23

221

Enlarged lymph nodes

114

2.20

3.34

1.8

2.0

3.20

2.26

ug/l

0.38

Other symptoms and signs involving the digestive system and abdomen

141

2.06

3.31

2.0

1.6

2.92

4.17

ug/l

0.24

Cardiovascular diseases

289

1.55

3.23

1.5

1.8

5.62

3.63

ug/l

0.19

181

Oedema, not elsewhere classified

212

1.83

3.19

1.6

1.9

14.75

3.58

ug/l

0.43

124

Other diseases of intestines

131

545

1.40

3.17

2.0

1.8

2.19

3.71

ug/l

0.78

326

Ovarian cyst

188

1.69

3.14

2.0

2.2

2.30

2.85

ug/l

0.44

126

Gastrointestinal diseases

292

1.51

3.09

1.7

1.9

1.66

3.99

ug/l

0.86

193

Other reaction to severe stress, and adjustment disorders

315

1.65

3.01

2.4

2.0

1.68

3.22

ug/l

1.01

189

Lichen ruber planus, wide definition including periferal and oral lichen planus

171

1.87

2.84

2.5

1.9

1.43

2.31

ug/l

2.22

L04AA Selective immunosuppressants

172

1.86

2.80

1.6

1.9

4.37

2.20

ug/l

0.63

Other diseases of blood and blood-forming organs, wide

172

1.86

2.80

2.7

1.8

2.56

1.95

ug/l

0.68

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

116

570

1.38

2.77

1.6

1.9

2.09

3.71

ug/l

0.97

352

Lower back pain or/and sciatica

121

612

1.37

2.76

1.4

1.9

2.94

3.42

ug/l

0.19

378

Other disorders of urethra and urinary system

482

1.43

2.71

2.5

1.8

2.49

3.83

ug/l

0.57

300

Low back pain

471

1.44

2.69

1.5

1.9

2.92

2.82

ug/l

0.05

296

Papulosquamous disorders

318

1.61

2.67

1.9

1.8

1.67

3.06

ug/l

0.83

177

Intestinal stricture

212

1.75

2.65

2.1

1.7

3.22

2.16

ug/l

0.54

112

Vulvovaginal ulceration/inflammation in other diseases

2.66

2.62

1.2

1.6

1.76

1.58

ug/l

—

Lichen planus, including avohilmo

155

1.87

2.60

2.3

2.0

1.43

2.28

ug/l

2.01

General examination and investigation of persons without complaint and reported diagnosis

263

1.50

2.59

2.0

1.8

2.09

4.39

ug/l

0.70

173

Disorders of skin appendages

377

1.54

2.56

1.7

1.9

2.24

2.86

ug/l

0.30

224

Other noninflammatory disorders of vagina

2.43

2.53

2.7

1.9

1.73

2.59

ug/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

112

533

1.37

2.53

1.8

2.73

3.53

ug/l

0.32

323

Endocrine, nutritional and metabolic diseases

104

379

1.40

2.52

2.0

1.7

4.70

3.68

ug/l

0.13

228

ILD medications: prednisolone, methylprednisolone, prednisone

132

560

1.33

2.46

1.4

1.9

2.50

3.53

ug/l

0.48

341

Unspecified fall

375

0.50

2.43

2.7

1.7

1.42

3.04

ug/l

—

216

Congenital malformations of ovaries, fallopian tubes and broad ligaments

2.51

2.36

1.2

2.0

1.56

1.63

ug/l

—

Exclusions for E4_PCOS_CONSORTIUM

103

472

1.37

2.33

1.9

2.0

2.57

3.84

ug/l

0.51

305

Metabolic disorders

110

506

1.35

2.30

2.5

1.7

2.33

2.82

ug/l

0.35

290

Inflammatory bowel disease treatment related agents

134

580

1.31

2.28

1.4

1.9

2.30

3.51

ug/l

0.63

354

Bronchiectasis

0.00

2.24

0.0

2.4

—

2.47

—

Left bundle-branch block

0.00

2.23

0.0

1.9

—

2.49

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

2.10

2.22

1.4

2.0

1.90

2.25

ug/l

0.34

Factors influencing health status and contact with health services

1.76

2.18

1.7

1.6

1.71

2.02

ug/l

0.24

Paralytic ileus and intestinal obstruction

173

1.74

2.15

2.2

1.6

2.64

2.39

ug/l

0.11

Septicaemia

248

1.59

2.13

2.5

1.5

3.67

2.31

ug/l

0.54

132

ILD medications

133

562

1.30

2.12

1.5

1.9

2.37

3.53

ug/l

0.57

342

Dorsalgia

117

479

1.32

2.11

1.8

1.9

2.16

2.81

ug/l

0.50

301

Sleep disorders (combined)

621

0.71

2.10

2.0

1.8

2.65

3.52

ug/l

0.34

375

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

110

596

1.32

2.09

2.1

1.7

5.19

3.07

ug/l

0.40

362

Unspecified privation

2.14

2.08

2.8

2.1

2.67

2.02

ug/l

—

Sleep apnoea, including avohilmo

596

0.71

2.04

2.0

1.8

2.67

3.58

ug/l

0.34

355

Oral corticosteroids

123

572

1.30

2.03

1.5

1.9

2.40

3.54

ug/l

0.57

347

Type 1 diabetes, strict definition, subgroup 1

0.00

2.03

0.0

2.0

—

1.68

—

Type 1 diabetes, strict definition

0.00

2.03

0.0

2.0

—

1.68

—

LSIL lesion of the cervix uteri, vagina or vulva

140

1.79

2.00

1.6

1.9

1.50

4.10

ug/l

0.68

DVT of lower extremities and pulmonary embolism

302

1.52

1.99

2.5

1.7

2.98

2.28

ug/l

0.51

168

Diseases of pulp and periapical tissues

280

1.54

1.96

2.3

1.9

7.37

2.24

ug/l

0.42

164

Carcinoma in situ of skin

2.36

1.95

1.0

1.9

1.32

2.09

ug/l

—

Renal failure

234

1.56

1.94

1.7

1.6

4.40

2.13

ug/l

0.94

127

Haemorrhoids and perianal venous thrombosis

218

1.61

1.92

1.1

1.7

1.16

2.33

ug/l

4.41

120

Shoulder lesions

414

1.35

1.92

1.8

2.87

2.88

ug/l

0.00

254

Mycoses

196

1.63

1.89

1.7

1.8

1.83

2.20

ug/l

0.40

101

DVT of lower extremities

143

1.75

1.88

1.9

2.0

1.63

2.28

ug/l

1.08

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.16

1.88

3.6

1.9

2.42

2.15

ug/l

—

ILD medications: immunosuppressive drugs

518

1.37

1.87

1.4

1.9

2.73

3.65

ug/l

0.31

316

Mental and behavioural disorders due to psychoactive substance use

397

0.59

1.87

1.7

1.8

2.86

2.91

ug/l

0.02

221

Venous thromboembolism

394

1.43

1.87

2.3

1.7

3.35

2.94

ug/l

0.16

230

False labour

202

0.53

1.87

1.3

2.2

1.29

4.77

ug/l

—

135

Hypothyroidism, drug reimbursement

2.38

1.87

1.2

1.9

1.31

1.39

ug/l

—

Other septicaemia

216

1.59

1.86

2.5

1.5

4.42

2.33

ug/l

0.68

113

Diseases of the musculoskeletal system and connective tissue

254

1.40

1.85

1.4

2.0

1.74

3.01

ug/l

0.63

161

Codeine

103

430

1.32

1.85

1.8

1.5

2.81

2.04

ug/l

0.81

256

Misadventures to patients during surgical and medical care

100

1.90

1.85

2.3

2.0

4.10

2.24

ug/l

—

Rosacea

1.94

1.84

1.0

2.0

3.45

2.17

ug/l

—

Other chronic obstructive pulmonary disease, including avohilmo

307

0.57

1.84

1.3

1.8

3.34

2.27

ug/l

—

176

101

1.88

1.80

3.5

1.5

2.78

1.85

ug/l

0.52

Sleep apnoea

568

0.72

1.80

2.1

1.7

2.77

3.66

ug/l

0.31

339

Substance abuse, excluding more controls

363

0.60

1.78

1.7

2.86

3.06

ug/l

0.06

207

Persons encountering health services for other counselling and medical advice, not elsewhere classified

124

555

1.27

1.77

2.7

1.5

4.70

3.19

ug/l

0.29

334

Other follicular disorders

2.44

1.75

1.7

2.2

3.16

1.73

ug/l

—

Substance abuse

393

0.61

1.73

1.7

1.8

2.86

2.92

ug/l

0.02

220

Polyp of the female genital tract

165

1.52

1.73

1.5

2.2

1.75

2.89

ug/l

1.78

109

Iridocyclitis in diseases classified elsewhere

3.87

1.72

1.2

2.0

1.16

2.54

ug/l

—

Kela-code for severe mental illness

296

0.54

1.71

2.1

1.8

1.85

3.16

ug/l

0.71

168

Insulin, fast-acting or short human

269

0.52

1.70

1.7

2.31

2.24

ug/l

—

139

Other otitis externa (chronic)

0.00

1.69

0.0

1.8

—

1.77

—

Injuries to the ankle and foot

559

0.68

1.69

1.4

1.9

2.30

3.57

ug/l

0.48

337

Organic, including symptomatic, mental disorders

249

0.58

1.65

1.5

1.6

1.41

2.28

ug/l

2.97

137

Dentinal caries

165

1.63

1.61

1.2

1.8

1.73

2.34

ug/l

1.03

Insulin, fast-acting

262

0.53

1.58

1.7

2.31

2.34

ug/l

—

136

Fall on same level involving ice and snow

485

0.66

1.58

2.7

1.8

1.74

2.86

ug/l

1.15

289

Hypothyroidism, strict autoimmune

454

1.30

1.55

2.1

1.8

5.04

3.44

ug/l

0.23

277

Persons encountering health services in other circumstances, wide

133

556

1.24

1.55

2.6

1.5

4.60

3.19

ug/l

0.28

334

Neuralgia and neuritis, unspecified

0.00

1.52

0.0

2.0

—

2.02

—

Crohn's disease of large intestine

0.00

1.52

0.0

2.2

—

1.88

—

Disorders of the thyroid gland

109

565

1.26

1.52

1.9

1.8

4.72

3.20

ug/l

0.24

346

Other disorders of breast

142

0.42

1.51

1.2

2.0

—

2.43

—

Type1 diabetes, definitions combined, early onset

0.00

1.51

0.0

2.3

—

1.87

—

Acute tubulo-interstitial nephritis

429

1.34

1.50

1.9

1.8

10.73

2.16

ug/l

0.58

261

Epilepsy

244

0.53

1.50

1.1

1.8

1.77

3.53

ug/l

—

135

Other or unspecified ileus, impaction or obstruction

123

1.71

1.50

2.4

1.7

3.28

2.21

ug/l

0.43

Soft tissue disorders

118

490

1.25

1.48

1.9

1.8

2.53

2.78

ug/l

0.13

305

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

262

1.38

1.48

2.2

1.9

2.47

4.05

ug/l

0.37

153

Autoimmune diseases excluding thyroid diseases

114

506

1.25

1.45

1.7

1.8

1.63

3.38

ug/l

1.10

303

Cervicobrachial syndrome

195

1.54

1.45

1.0

1.8

1.35

3.47

ug/l

0.91

121

Autoimmune diseases excluding thyroid diseases, strict definition

111

495

1.25

1.41

1.7

1.8

1.63

3.36

ug/l

1.05

296

Excessive, frequent and irregular menstruation

189

1.41

1.40

1.5

2.2

1.62

2.85

ug/l

2.77

126

Osteoporosis

203

1.50

1.39

3.2

1.4

2.73

2.58

ug/l

0.11

111

Other symptoms and signs involving the nervous and musculoskeletal systems

362

0.63

1.39

1.8

1.93

3.01

ug/l

0.59

212

Other dorsopathies, not elsewhere classified

113

479

1.24

1.38

2.0

1.9

2.04

2.81

ug/l

0.64

301

Symptoms and signs involving the nervous and musculoskeletal systems

481

0.69

1.38

1.6

1.9

1.75

2.85

ug/l

0.92

291

Dental caries

188

1.53

1.37

1.2

2.0

1.87

2.23

ug/l

0.51

105

Atherosclerosis, excluding cerebral and coronary sclerosis

210

0.57

1.36

1.2

1.5

3.25

2.19

ug/l

—

111

Unspecified mental disorder

336

0.62

1.36

1.9

1.66

3.04

ug/l

0.96

200

Use of hypnotics and sedatives

118

554

1.23

1.35

2.6

1.7

6.03

2.93

ug/l

0.33

338

Hyperprolactinaemia

0.00

1.34

0.0

2.4

—

1.83

—

Gonarthrosis,primary

463

1.26

1.34

1.4

1.8

2.28

2.99

ug/l

0.50

283

Sacroiliitis, not elsewhere classified

0.00

1.33

0.0

2.8

—

2.02

—

Bacterial pneumonia, not elsewhere classified

263

0.61

1.32

1.2

1.6

2.55

2.32

ug/l

—

143

L01XE Protein kinase inhibitors

0.00

1.32

0.0

1.6

—

1.67

—

Injury, poisoning and certain other consequences of external causes

267

1.31

1.5

1.9

1.74

2.31

ug/l

0.86

157

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

1.31

0.0

1.7

—

1.81

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

444

1.32

1.31

2.1

1.7

3.21

2.87

ug/l

0.12

259

Faecal incontinence

1.85

1.29

2.3

1.6

2.92

2.10

ug/l

—

Glucosamine medication

327

1.34

1.29

1.1

1.9

2.41

2.55

ug/l

0.06

197

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

244

0.57

1.28

2.1

2.0

2.13

3.43

ug/l

—

150

Autoimmune diseases related-to ILD

632

1.25

1.28

1.7

1.8

1.66

3.65

ug/l

1.52

378

Other/unspecified dorsalgia

308

1.39

1.28

1.8

1.89

3.17

ug/l

0.74

192

Used for control exclusion in common control thyroid runs

116

479

1.23

1.27

1.8

4.26

3.40

ug/l

0.12

288

COPD related to multimorbidity

216

0.58

1.27

1.4

1.6

2.09

2.16

ug/l

—

115

COPD, hospital admissions 1, only main diagnosis

186

0.55

1.27

1.0

1.7

2.21

2.19

ug/l

—

Diverticular disease of intestine

376

1.29

1.26

1.5

1.7

1.96

3.02

ug/l

0.69

213

Biguanides

103

513

1.24

1.26

1.5

1.9

2.43

2.85

ug/l

0.26

306

Dorsopathies

115

479

1.23

1.25

1.9

1.96

2.81

ug/l

0.76

301

Congenital malformations, deformations and chromosomal abnormalities

472

1.30

1.24

1.5

1.9

1.57

3.90

ug/l

1.26

282

Appendicitis, broad definition

609

0.75

1.24

1.8

1.70

3.49

ug/l

1.23

369

Other complications of surgical and medical care, not elsewhere classified

1.86

1.23

2.6

2.2

22.78

2.20

ug/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

241

0.58

1.23

2.1

1.7

2.13

3.40

ug/l

—

147

Nephropathy related operations

1.86

1.23

1.1

1.7

1.63

1.79

ug/l

—

Headache

455

1.29

1.23

1.5

1.8

2.06

2.79

ug/l

0.54

285

Implicit viral Sepsis

123

1.63

1.23

1.0

1.9

1.93

ug/l

0.00

Viral Sepsis

123

1.63

1.23

1.0

1.9

1.93

ug/l

0.00

Disorders of vestibular function (Vertigo)

396

0.68

1.23

1.1

1.8

2.28

3.00

ug/l

0.34

229

COPD, early/later onset

256

0.63

1.23

1.3

1.7

3.34

2.20

ug/l

—

140

Sequelae of external causes of morbidity and mortality

187

1.50

1.23

2.0

1.8

1.57

2.25

ug/l

1.27

Paroxysmal tachycardia

144

1.53

1.22

1.1

1.7

1.95

2.32

ug/l

0.21

Peripheral artery disease

223

0.61

1.20

1.2

1.5

3.10

2.17

ug/l

0.28

120

Premature rupture of membranes

167

0.57

1.19

1.5

2.1

24.69

5.22

ug/l

—

108

Cough

357

0.67

1.19

2.0

1.8

1.83

3.17

ug/l

0.90

224

Abnormal findings on diagnostic imaging of lung

314

1.36

1.19

1.7

1.8

3.47

2.14

ug/l

0.52

176

COPD, hospital admissions

254

0.63

1.19

1.3

1.7

3.34

2.19

ug/l

—

138

Dislocation, sprain and strain of joints and ligaments of knee

497

0.73

1.18

1.5

1.9

2.56

2.70

ug/l

0.04

294

Diseases of appendix

612

0.76

1.18

1.8

1.70

3.48

ug/l

1.24

371

Gonarthrosis, primary, with knee surgery

348

1.31

1.17

1.5

1.8

2.33

2.42

ug/l

0.07

212

Bacterial pneumoniae

275

0.64

1.16

1.4

1.6

3.01

2.27

ug/l

0.46

153

Dislocation, sprain and strain of joints and ligaments of head

0.00

1.16

0.0

1.9

—

2.04

—

Foreign body or object entering through skin

0.00

1.16

0.0

1.8

—

2.05

—

Primary angle-closure glaucoma

0.00

1.16

0.0

2.0

—

2.30

—

Immunodeficiencies

0.00

1.16

0.0

1.8

—

2.23

—

Acute bronchitis

303

0.65

1.15

2.8

1.7

1.45

2.23

ug/l

1.76

166

Nontoxic diffuse goitre

0.00

1.15

0.0

1.8

—

2.27

—

Asthma and opportunity respiratory infection

0.00

1.15

0.0

2.2

—

2.54

—

Dialysis, with operation codes

1.81

1.15

1.0

1.6

2.25

1.75

ug/l

—

Viral infections characterized by skin and mucous membrane lesions

325

1.35

1.14

1.3

1.8

2.06

3.19

ug/l

0.63

186

Injuries to the wrist and hand

656

0.79

1.14

1.6

1.8

8.67

2.77

ug/l

0.40

401

Pain in limb

475

1.25

1.14

2.0

1.8

9.82

2.79

ug/l

0.49

296

Hypoparathyroidism

0.00

1.14

0.0

2.3

—

2.65

—

Contusion of other and unspecified parts of foot

0.00

1.14

0.0

1.8

—

1.99

—

Non-small cell lung cancer, adenocarcinoma

0.00

1.14

0.0

2.0

—

2.13

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

0.00

1.14

0.0

2.0

—

2.13

—

Acute appendicitis

587

0.75

1.14

1.9

1.8

1.70

3.53

ug/l

1.21

355

Other maternal disorders predominantly related to pregnancy

436

0.76

1.13

1.6

2.1

2.13

3.84

ug/l

0.73

276

Benign neoplasm: Stomach

1.75

1.12

1.1

1.8

1.92

2.14

ug/l

—

COPD

244

0.64

1.12

1.3

1.9

3.34

2.37

ug/l

—

135

Other acute lower respiratory infections

372

0.69

1.11

2.4

1.8

1.57

2.94

ug/l

1.01

209

Appendectomy

560

1.26

1.11

1.7

1.9

5.81

3.14

ug/l

0.31

338

Asthma-related pneumonia

257

0.62

1.10

1.3

1.8

1.64

2.37

ug/l

—

141

Oter anti-inflammatory and antirheumatic agents, non-steroids

1.56

1.10

1.0

2.0

1.69

2.75

ug/l

—

Medical observation and evaluation for suspected diseases and conditions

263

1.29

1.10

1.3

1.8

2.67

4.39

ug/l

0.43

173

Diseases of external ear

257

0.62

1.10

2.2

1.7

3.76

2.22

ug/l

—

130

Oxicams

1.53

1.09

1.3

2.0

3.32

2.68

ug/l

—

Disorders of lens

354

1.27

1.09

1.6

1.8

2.41

2.20

ug/l

0.18

206

Sarcoidosis

104

1.64

1.09

2.1

1.8

1.93

ug/l

0.00

Exposure to other specified factors

589

0.76

1.08

1.5

1.8

1.92

2.69

ug/l

0.89

358

Explicit Sepsis

282

1.36

1.08

2.1

1.7

3.50

2.30

ug/l

0.43

161

Autoimmune diseases

119

507

1.20

1.07

1.8

4.25

3.37

ug/l

0.14

304

Pain, not elsewhere classified

210

1.43

1.07

1.6

1.8

3.82

3.39

ug/l

0.07

121

Cervicalgia

177

1.47

1.07

1.5

1.8

1.59

2.21

ug/l

1.05

104

Methotrexate

129

1.55

1.05

1.3

2.0

4.69

2.21

ug/l

0.53

Hypothyroidism, other/unspecified

101

552

1.21

1.04

2.0

1.8

4.57

3.22

ug/l

0.22

340

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

162

1.48

1.03

2.5

2.0

1.50

4.17

ug/l

0.87

Other (not insulin) diabetes medications

105

526

1.20

1.03

1.4

1.9

2.38

3.81

ug/l

0.67

315

Sequelae with surgical and medical care as external cause

146

1.51

1.03

2.0

1.9

1.72

1.97

ug/l

0.35

Malignant neoplasm of breast, HER-negative

215

0.60

1.02

1.7

2.1

1.49

2.54

ug/l

—

124

Complications predominantly related to the puerperium

275

0.65

1.01

2.0

2.3

1.65

3.33

ug/l

—

166

Hypothyreosis and Thyroxine purchase for inclusion criteria

104

572

1.20

1.01

2.0

1.8

4.47

3.19

ug/l

0.21

347

Obstructed labour due to malposition and malpresentation of fetus

225

0.63

1.01

1.1

2.1

1.48

5.66

ug/l

—

138

Gonarthrosis [arthrosis of knee](FG)

392

1.23

1.01

1.4

1.8

2.25

3.00

ug/l

0.44

237

Hernia of abdominal wall, postoperative

1.77

1.00

1.0

1.2

2.35

2.01

ug/l

—

Benign neoplasm: Colon

378

1.30

1.00

1.3

1.8

1.81

2.44

ug/l

1.29

220

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

309

0.68

0.99

1.5

2.1

1.52

3.13

ug/l

1.06

185

Other chronic obstructive pulmonary disease

238

0.66

0.99

1.3

1.9

3.34

2.36

ug/l

—

134

Injuries to the thorax

321

0.68

0.99

3.5

1.6

4.59

2.25

ug/l

0.65

172

Other retinal disorders

388

0.74

0.98

1.6

1.7

1.95

2.47

ug/l

0.87

222

Other diseases of urinary system

114

540

1.19

0.97

2.1

1.7

2.02

3.70

ug/l

0.94

332

0.00

0.97

0.0

1.4

—

2.38

—

Diseases of arteries, arterioles and capillaries

369

0.75

0.97

1.3

1.7

2.36

2.40

ug/l

0.02

205

Generalized epilepsy

0.00

0.97

0.0

1.9

—

1.95

—

Endometriosis

187

1.34

0.97

1.8

2.2

1.68

2.84

ug/l

1.83

125

Persons encountering health services in circumstances related to reproduction

321

1.27

0.97

2.4

2.0

2.11

3.16

ug/l

0.64

200

Purpura and other haemorrhagic conditions

1.63

0.97

2.1

1.8

5.10

1.85

ug/l

—

Triptan medication for migraine, min. 3 purchases

452

0.77

0.97

1.1

2.1

1.33

3.89

ug/l

1.41

275

Rotator cuff syndrome

379

1.25

0.97

1.8

1.7

3.78

2.94

ug/l

0.33

229

Lesion of radial nerve

0.00

0.96

0.0

2.2

—

1.97

—

Follicular cysts of skin and subcutaneous tissue

124

1.53

0.96

2.5

1.8

1.36

1.96

ug/l

—

Pain in joint

302

1.27

0.96

1.4

1.7

2.39

2.93

ug/l

0.23

193

Diseases of liver

247

0.65

0.95

1.5

1.8

1.85

2.14

ug/l

—

130

Osteomyelitis

0.00

0.95

0.0

1.8

—

1.94

—

Paracetamol of NSAID medication

1.68

0.95

1.1

2.3

1.20

2.73

ug/l

—

Certain disorders involving the immune mechanism

141

1.49

0.94

1.9

2.0

1.94

2.00

ug/l

0.04

Hypothyroidism, strict autoimmune, 3 medication purchases required

559

1.20

0.94

2.0

1.8

4.64

3.22

ug/l

0.23

340

Internal derangement of knee

316

0.69

0.93

1.5

2.0

1.25

2.99

ug/l

1.36

199

Asthma-related pneumonia or sepsis

257

0.66

0.93

1.3

1.8

1.59

2.37

ug/l

—

141

Asthma, hospital admissions 3, pneumonia

257

0.66

0.93

1.3

1.8

1.59

2.37

ug/l

—

141

Cholelithiasis

531

1.20

0.93

1.5

1.9

2.13

3.70

ug/l

0.79

328

Disorders of choroid and retina

487

0.79

0.92

1.6

1.7

2.33

2.90

ug/l

0.34

283

Senile cataract

318

1.25

0.91

1.6

1.8

2.24

2.26

ug/l

0.01

189

375

0.74

0.90

2.5

1.7

2.92

3.00

ug/l

0.03

207

Benign neoplasm of colon, rectum, anus and anal canal

418

1.25

0.90

1.3

1.8

1.73

2.50

ug/l

1.90

242

Fracture of foot, except ankle

195

0.61

0.90

1.3

1.7

1.21

2.20

ug/l

—

109

Pregnancy, childbirth and the puerperium

171

1.32

0.89

2.4

1.9

2.38

3.18

ug/l

0.65

108

Mental and behavioural disorders due to alcohol

339

0.72

0.89

1.7

2.86

3.00

ug/l

0.04

184

Benign lipomatous neoplasm

236

1.36

0.89

1.8

1.56

2.33

ug/l

1.28

127

Insulin, fast-acting (human)

102

0.49

0.89

3.0

1.7

3.28

1.58

ug/l

—

Other diseases of anus and rectum

219

1.37

0.88

2.2

1.8

2.56

2.26

ug/l

0.15

119

Bacterial Sepsis

264

1.31

0.88

2.3

1.6

3.45

2.30

ug/l

0.47

149

Stroke, including SAH

350

0.76

0.86

2.0

1.8

2.87

2.46

ug/l

0.15

198

Acute appendicitis, no complications

481

0.77

0.86

1.7

1.9

1.72

3.79

ug/l

1.05

285

Disorders of other endocrine glands

374

0.74

0.86

1.2

1.8

1.67

3.12

ug/l

1.07

224

Diseases of salivary glands

170

1.41

0.85

1.1

1.9

1.50

2.32

ug/l

0.81

Artificial joint operation, meniscal resection

491

1.19

0.84

1.4

1.8

2.47

2.68

ug/l

0.11

290

Condition for Implicit Sepsis (Organ dysfunction codes)

497

1.20

0.84

1.8

1.7

3.08

2.83

ug/l

0.11

307

Disorders of breast

517

0.79

0.83

1.3

2.1

1.84

3.82

ug/l

1.16

335

Propionic acid derivatives

101

1.39

0.83

1.3

1.9

1.80

2.73

ug/l

—

Other disorders of amniotic fluid and membranes

138

0.57

0.83

2.6

2.2

1.43

2.59

ug/l

—

L04AX Other immunosuppressants

470

1.23

0.82

1.2

1.9

2.83

2.87

ug/l

0.01

282

Adhesive capsulitis of shoulder

138

1.45

0.81

2.0

1.9

3.45

2.38

ug/l

0.37

Pulmonary heart disease, diseases of pulmonary circulation

223

1.35

0.81

2.6

1.7

3.70

2.21

ug/l

0.84

119

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

630

0.84

0.80

1.5

1.8

2.51

3.49

ug/l

0.44

378

Gestational diabetes (for exclusion)

266

0.74

0.79

1.4

1.9

2.22

4.90

ug/l

0.69

169

Systemic sclerosis

0.00

0.79

0.0

2.4

—

2.46

—

Procedures for purposes other than remedying health state

0.00

0.79

0.0

2.1

—

2.31

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

0.00

0.79

0.0

1.3

—

2.32

—

Oesophageal obstruction

0.00

0.79

0.0

2.2

—

2.63

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

0.00

0.79

0.0

1.8

—

2.31

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

0.00

0.79

0.0

2.0

—

2.10

—

Dental caries 1 and operation codes

413

1.18

0.79

1.3

1.8

1.59

3.81

ug/l

1.16

247

Injuries involving multiple body regions

0.00

0.79

0.0

1.6

—

1.78

—

Second line medication for Crohn's disease

482

1.22

0.79

1.2

1.9

2.82

2.84

ug/l

0.00

288

Myocardial infarction, without ST-elevation

217

0.68

0.78

1.0

1.5

2.66

2.08

ug/l

—

113

0.00

0.78

0.0

1.5

—

1.83

—

Long labour

236

0.70

0.78

1.8

2.0

1.78

5.60

ug/l

0.98

145

Other diseases of intestine

1.59

0.78

2.2

1.5

10.45

2.05

ug/l

—

Other intervertebral disc disorders

450

1.18

0.77

1.6

1.9

10.53

2.83

ug/l

0.52

282

Diseases of inner ear

442

0.77

1.8

1.7

2.80

3.06

ug/l

0.10

255

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

0.00

0.77

0.0

2.2

—

2.63

—

Antihypertensive medication - note that there are other indications

312

1.21

0.76

1.3

2.0

6.44

3.98

ug/l

0.21

197

Alcohol use disorder, Swedish definition

345

0.75

0.76

2.7

1.7

3.03

3.10

ug/l

0.02

186

Other disorders of penis

0.00

0.76

0.0

1.0

—

1.65

—

361

0.76

0.75

2.6

1.7

2.99

2.94

ug/l

0.02

198

Dental caries 2 and operation codes, only avohilmo

350

1.21

0.75

1.5

2.0

1.60

2.92

ug/l

0.98

216

Uterine polyps

1.60

0.74

1.2

2.1

2.37

2.36

ug/l

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

218

0.68

0.74

1.3

2.0

1.44

3.52

ug/l

—

129

Malignant neoplasm of bladder

2.08

0.74

1.2

1.9

6.14

2.14

ug/l

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

204

0.73

0.74

1.4

2.0

1.73

5.76

ug/l

0.92

131

Other abnormal products of conception

232

0.75

0.73

1.3

2.1

1.06

4.32

ug/l

0.95

146

Pneumonia, organism unspecified

571

0.84

0.73

1.6

1.7

2.51

3.65

ug/l

0.47

344

Other heart diseases, wide

528

1.16

0.73

1.8

1.9

1.77

3.81

ug/l

1.27

327

Temporomandibular joint disorders

133

1.43

0.73

1.2

1.8

1.39

3.84

ug/l

0.73

Stroke, excluding SAH

316

0.78

0.72

1.8

1.7

2.84

2.42

ug/l

0.16

175

Diseases of oesophagus, stomach and duodenum

111

586

1.15

0.71

1.5

1.9

1.89

3.66

ug/l

1.17

366

Neurotic, stress-related and somatoform disorders

588

1.16

0.71

2.1

1.8

1.61

3.64

ug/l

1.44

359

Other diseases of lip and oral mucosa

134

1.42

0.71

2.2

2.1

4.59

2.30

ug/l

—

Tumor necrosis factor alpha inhibitors

109

1.47

0.70

1.2

1.7

3.95

1.73

ug/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

229

0.70

1.1

1.8

50.40

3.28

ug/l

—

131

Myocardial infarction, strict

243

0.75

0.70

1.4

1.5

3.24

2.37

ug/l

0.44

137

Cystitis

506

1.16

0.69

1.9

1.8

2.06

3.75

ug/l

0.87

315

IBD patients in KELA-register

169

1.36

0.69

1.1

1.7

1.24

2.06

ug/l

2.71

Inflammatory bowel disease, strict (require KELA)

169

1.36

0.69

1.1

1.7

1.24

2.06

ug/l

2.74

Intestinal infectious diseases

643

0.85

0.68

1.6

1.8

2.42

3.53

ug/l

0.59

387

Diseases of the respiratory system

354

1.17

0.68

1.9

1.8

2.10

4.45

ug/l

0.89

226

Osteopathies and chondropathies

431

1.21

0.68

2.7

1.7

2.33

2.90

ug/l

0.35

249

Ischaemic Stroke, excluding all haemorrhages

293

0.77

0.68

1.9

1.8

3.04

2.35

ug/l

0.25

163

Pulmonary heart disease

213

1.31

0.68

2.7

1.7

3.70

2.25

ug/l

0.81

112

Chronic periapical parodontitis

161

1.37

0.68

2.1

2.0

13.12

2.47

ug/l

0.43

Anti-inflammatory and antirheumatic products, non-steroids

101

1.34

0.67

1.3

1.9

1.94

2.73

ug/l

—

Blepharochalasis

261

0.73

0.67

2.4

1.8

1.28

2.34

ug/l

2.71

151

Need for other prophylactic measures

1.63

0.67

2.0

1.7

2.23

1.80

ug/l

—

Ethmoidectomy

0.54

0.66

1.2

1.9

1.92

1.88

ug/l

—

Mixed conductive and sensorineural hearing loss

1.49

0.66

1.8

1.47

2.19

ug/l

—

Benign neoplasm of ovary

179

1.34

0.66

1.5

2.1

3.23

2.29

ug/l

0.37

105

Pulmonary embolism

214

1.31

0.66

2.7

1.7

3.70

2.23

ug/l

0.82

113

Other obstetric conditions, not elsewhere classified

207

0.75

0.66

1.4

2.0

1.71

5.71

ug/l

0.93

133

Benign neoplasm of other and ill-defined parts of digestive system

145

1.38

0.65

1.1

2.0

1.96

2.26

ug/l

0.21

Implicit Sepsis

440

1.18

0.65

1.9

1.6

3.26

2.94

ug/l

0.12

265

Menorrhagia

176

1.26

0.65

1.4

2.2

2.16

2.89

ug/l

0.91

116

Dental caries 3 and operation codes

441

1.15

0.65

1.3

1.8

1.58

3.69

ug/l

1.19

264

Sciatica+with lumbago

417

1.21

0.65

1.2

1.9

2.72

2.84

ug/l

0.04

261

Bacterial pneumonia (organism specified)

288

0.76

0.64

1.3

1.6

2.69

2.24

ug/l

0.30

156

Carpal tunnel syndrome

504

1.18

0.64

2.0

1.8

2.28

2.81

ug/l

0.39

306

Anxiety disorders

592

1.15

0.64

2.1

1.8

1.61

3.63

ug/l

1.44

360

Infections of the skin and subcutaneous tissue

420

1.21

0.64

2.2

1.8

2.00

2.91

ug/l

0.64

240

Other specified/unspecified arthritis

224

0.71

0.63

1.6

2.1

2.07

3.22

ug/l

0.43

139

Cardiac arrhythmias

388

1.18

0.61

1.6

1.8

1.53

4.25

ug/l

1.26

242

Cholelithiasis, broad definition with cholecystitis

537

1.15

0.61

1.5

1.9

2.16

3.73

ug/l

0.79

331

Enteropathic arthropathies

0.00

0.60

0.0

1.9

—

2.33

—

Amblyopia ex anopsia

0.00

0.60

0.0

1.8

—

2.11

—

GI-bleeding

200

1.30

0.60

1.7

1.89

2.15

ug/l

0.24

103

Allergic rhinitis

253

0.74

0.60

1.9

2.1

1.63

3.26

ug/l

0.89

159

Other bursitis of hip

0.00

0.60

0.0

1.9

—

2.04

—

Systemic sclerosis, icd10

0.00

0.60

0.0

2.2

—

2.54

—

Other disorders of bone density and structure

0.00

0.60

0.0

1.8

—

1.97

—

Dronedarone medication

0.00

0.60

0.0

2.5

—

3.11

—

Progressive vascular leukoencephalopathy

0.00

0.60

0.0

2.5

—

3.18

—

Symptoms and signs involving emotional state

0.00

0.60

0.0

2.6

—

2.21

—

Systemic atrophies primarily affecting the central nervous system

0.00

0.60

0.0

1.7

—

2.08

—

Somnolence, stupor and coma

0.00

0.60

0.0

2.3

—

1.89

—

Caught, crushed, jammed or pinched in or between objects

0.00

0.60

0.0

2.0

—

1.90

—

Diabetic retinopathy

126

0.70

0.60

1.1

1.7

2.42

2.35

ug/l

—

Medical treatment for female infertility

209

0.72

0.60

1.0

2.0

2.14

3.43

ug/l

—

127

Cerebrovascular diseases

421

0.83

0.59

2.2

1.6

2.42

2.40

ug/l

0.01

242

Complications of labour and delivery

431

0.85

0.59

1.9

2.0

2.11

4.10

ug/l

0.90

267

Nerve, nerve root and plexus disorders

108

599

1.13

0.59

1.7

1.8

2.58

3.55

ug/l

0.47

368

Benign neoplasm: Liver/bile ducts

0.00

0.59

0.0

1.9

—

1.82

—

Bursitis of shoulder

0.00

0.59

0.0

1.8

—

2.06

—

Benign neoplasm: Long bones of lower limb

0.00

0.59

0.0

2.0

—

2.18

—

Paralytic ileus

0.00

0.59

0.0

1.6

—

2.46

—

Dizziness and giddiness

525

1.16

0.59

1.6

1.8

2.02

2.90

ug/l

0.64

319

Voice disturbances

232

0.73

0.59

1.9

2.11

3.44

ug/l

0.41

124

Presence of other functional implants

323

0.81

0.59

1.6

1.9

2.59

2.55

ug/l

0.02

188

Myocardial infarction

264

0.79

0.59

1.4

1.5

3.05

2.46

ug/l

0.30

148

Other disorders starting during childhood or adolecense, excluding more controls

0.00

0.58

0.0

1.5

—

2.09

—

Diabetes mellitus in pregnancy

224

0.78

0.58

1.4

2.0

2.17

5.30

ug/l

0.71

146

Systemic sclerosis (FG)

0.00

0.58

0.0

2.3

—

2.12

—

Other renal tubulo-interstitial diseases

0.00

0.58

0.0

2.3

—

2.18

—

Other and unspecified mononeuropathies, also in other diseases

0.00

0.58

0.0

2.1

—

1.81

—

Muscle strain

0.00

0.58

0.0

1.8

—

1.77

—

Other and unspecified injuries of wrist and hand

0.00

0.58

0.0

1.9

—

2.06

—

Embolic stroke

0.00

0.58

0.0

2.4

—

2.94

—

Disorders of thyroid, IBD co-morbidities

133

1.32

0.58

2.2

1.22

3.88

ug/l

0.83

Cholecystectomy

549

1.16

0.58

1.5

1.9

1.85

3.71

ug/l

1.13

337

External causes of morbidity and mortality

351

1.16

0.58

1.4

1.8

1.53

2.32

ug/l

2.72

207

Contraceptive management

248

1.22

0.57

2.0

2.1

1.79

3.37

ug/l

0.82

154

Dislocation, sprain and strain of joints and ligaments at neck level

123

1.38

0.57

1.6

1.7

1.97

1.91

ug/l

—

Cellulitis

149

1.34

0.57

2.1

1.8

2.25

1.99

ug/l

0.13

Postmenopausal osteoporosis with pathological fracture

1.48

0.57

6.6

1.9

3.63

2.68

ug/l

—

COPD differential diagnosis

431

1.14

0.57

1.6

1.8

2.18

4.05

ug/l

0.79

267

ILD differential diagnosis

431

1.14

0.57

1.6

1.8

2.18

4.05

ug/l

0.79

267

Diabetes medication

107

576

1.13

0.56

1.6

1.8

2.37

3.64

ug/l

0.65

351

Mental and behavioural disorders due to alcohol, excluding acute intoxication

286

0.77

0.56

1.8

1.5

3.00

3.23

ug/l

0.06

150

Type 2 diabetes, definitions combined

515

1.14

0.56

1.4

1.9

2.41

3.83

ug/l

0.64

309

Pneumonias (Asthma/COPD co-morbidities)

635

0.87

0.56

1.5

1.8

2.44

3.48

ug/l

0.49

382

Artrosis, including avohilmo

416

0.86

0.56

1.5

1.9

2.65

3.97

ug/l

0.45

260

LSIL lesion of the cervix uteri

115

1.39

0.56

1.1

1.9

1.62

1.94

ug/l

—

Biological medication for rheuma

115

1.39

0.56

1.2

1.7

3.95

1.74

ug/l

—

Other diseases of upper respiratory tract

116

538

1.12

0.56

1.7

1.8

2.01

3.72

ug/l

0.98

344

Other predominantly sexually transmitted diseases, not elsewhere classified

141

1.35

0.56

1.7

2.0

1.48

4.12

ug/l

0.71

Hypertrophy of breast

195

0.72

0.56

1.4

2.2

1.38

3.65

ug/l

—

112

Endometriosis ASRM stages 1,2

195

0.72

0.56

2.1

2.0

1.50

3.87

ug/l

—

114

FESS (DNB20)

0.56

1.2

2.0

1.92

1.91

ug/l

—

Fracture of lumbar spine and pelvis

160

0.69

0.55

4.3

1.8

1.79

2.17

ug/l

0.54

Dentofacial anomalies [including malocclusion]

254

1.25

0.55

1.8

2.2

1.35

2.28

ug/l

3.95

151

Polycystic ovarian syndrome, consortium definition

520

0.87

0.55

1.6

2.0

2.37

3.77

ug/l

0.62

330

Open wound of wrist and hand

304

0.78

0.55

2.1

1.6

1.69

3.21

ug/l

0.82

166

Phlebitis and thrombophlebitis (not including DVT)

177

1.30

0.54

1.5

1.8

1.76

2.22

ug/l

0.67

Psychiatric diseases

100

565

0.89

0.54

2.4

1.7

1.89

3.78

ug/l

1.18

343

Other diseases of hard tissues of teeth

431

1.16

0.54

1.5

1.8

1.56

3.60

ug/l

1.11

263

Other enthesopathies

258

1.24

0.53

1.4

1.8

1.75

3.13

ug/l

0.63

154

Type 2 diabetes, strict (exclude DM1)

518

1.13

0.53

1.4

1.9

2.41

3.83

ug/l

0.64

311

Convulsions, not elsewhere classified

145

0.68

0.53

1.1

1.9

2.30

2.32

ug/l

—

Type 2 diabetes

103

544

1.12

0.52

1.5

1.9

2.17

3.73

ug/l

0.83

327

Acute upper respiratory infections

107

598

1.12

0.52

1.8

1.71

3.64

ug/l

1.40

374

Extrapyramidal and movement disorders

271

0.77

0.52

1.0

1.8

1.94

2.37

ug/l

—

151

Nasal polyp

126

1.35

0.51

1.2

1.6

3.57

1.98

ug/l

—

Hypertrophy of breast in women and men

203

0.74

0.51

1.4

2.1

1.38

3.56

ug/l

—

116

Diabetic retinopathy, excluding more controls

0.70

0.51

1.1

1.7

2.63

1.86

ug/l

—

Diagnoses used for exclusion with ILD

170

1.29

0.51

1.9

1.99

2.40

ug/l

0.41

All pneumoniae

634

0.88

0.51

1.5

1.8

2.44

3.48

ug/l

0.49

381

Achilles tendinitis

1.47

0.50

1.5

1.9

2.32

2.09

ug/l

—

Peritonsillar abscess

168

0.71

0.50

3.3

1.9

1.51

3.92

ug/l

—

108

Irregular menses

440

0.85

0.49

1.6

2.1

2.47

3.83

ug/l

0.43

277

Fracture of lower leg, including ankle

464

0.84

0.49

1.1

1.8

3.24

2.77

ug/l

0.17

280

Maternal care for other known or suspected fetal problems

159

0.77

0.49

1.4

2.1

17.57

5.34

ug/l

—

107

Sulfasalazine

261

1.23

0.49

1.5

2.0

1.34

3.19

ug/l

0.98

146

Other cataract

265

1.20

0.49

1.8

1.9

1.99

2.25

ug/l

0.27

154

Asthma (diagnoses ohter than nonallergic)

636

1.13

0.49

1.5

1.8

2.37

3.49

ug/l

0.60

391

Hypertensive heart and/or renal disease

121

0.70

0.49

1.4

1.5

1.65

2.27

ug/l

—

Injuries to the hip and thigh

306

0.81

0.48

1.8

1.7

3.89

2.37

ug/l

0.40

169

Pure hypercholesterolaemia

392

0.86

0.48

1.7

1.6

1.96

2.21

ug/l

0.29

223

Type 2 diabetes, definitions combined, including avohilmo

524

1.12

0.47

1.5

1.9

2.06

3.81

ug/l

0.93

314

Endometriosis ASRM stages 3,4

256

0.78

0.47

1.8

2.0

1.43

3.50

ug/l

1.20

152

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

102

1.37

0.47

2.5

1.9

1.22

2.11

ug/l

—

Recurring oral aphthae, including avohilmo

102

1.37

0.47

2.1

1.7

2.12

2.04

ug/l

—

Cardiomyopathies, Primary/intrinsic

1.47

0.47

1.0

1.8

2.58

2.31

ug/l

—

Mouth breathing

288

0.80

0.46

1.6

1.8

3.77

3.21

ug/l

0.12

154

Poisoning by drugs, medicaments and biological substances

188

0.74

0.46

1.7

1.8

1.78

3.74

ug/l

—

104

Impingement syndrome of shoulder

200

1.25

0.46

1.6

1.7

2.50

2.32

ug/l

0.08

115

Insulin, combination of fast acting with intermediate-acting or long-acting

416

0.84

0.46

1.9

1.7

2.50

2.98

ug/l

0.20

234

Transient ischemic attack

317

1.18

0.46

1.2

1.8

2.81

2.35

ug/l

0.25

175

Injuries to the head

648

0.89

0.46

1.6

1.8

1.80

3.53

ug/l

1.34

401

350

0.82

0.45

1.2

2.0

1.58

3.05

ug/l

1.09

208

Coxarthrosis, primary

381

1.16

0.45

1.6

1.7

3.00

2.30

ug/l

0.33

228

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

419

0.84

0.45

1.6

1.8

2.05

2.89

ug/l

0.51

259

Other diseases of the digestive system

201

1.24

0.44

1.7

1.89

2.24

ug/l

0.34

104

Diabetes, varying definitions

105

566

1.11

0.44

1.7

1.8

2.13

3.66

ug/l

0.86

345

Behavioural syndromes associated with physiological disturbances and physical factors

253

0.79

0.44

1.4

1.9

1.36

3.38

ug/l

—

152

Excluding asthma or asthma-COPD overlap

436

1.11

0.44

1.6

1.8

2.23

4.01

ug/l

0.74

271

Medical abortion

417

1.12

0.44

2.0

4.56

3.59

ug/l

0.12

265

Disorders of gallbladder, biliary tract and pancreas

569

1.11

0.43

1.7

1.9

2.25

3.66

ug/l

0.74

351

Symptoms and signs involving cognition, perception, emotional state and behaviour

593

1.11

0.43

1.7

1.8

1.86

3.64

ug/l

1.11

364

Asthma-related infections

440

0.85

0.43

1.3

1.9

1.47

2.93

ug/l

1.55

265

Asthma, hospital admission 2, infections

440

0.85

0.43

1.3

1.9

1.47

2.93

ug/l

1.55

265

Other and unspecified tonsillitis

195

0.78

0.42

1.9

1.52

3.63

ug/l

0.85

118

Inflammatory bowel disease

248

1.21

0.42

1.6

1.8

1.42

3.25

ug/l

0.86

136

Vasomotor and allergic rhinitis

323

0.82

0.42

1.7

2.0

1.44

4.38

ug/l

1.11

205

Symptoms and signs involving speech and voice

284

0.81

0.42

1.7

1.8

1.88

3.24

ug/l

0.56

152

Alcohol use disorder, ICD-based

262

0.80

0.42

1.9

1.5

3.17

3.27

ug/l

0.02

134

Finngen Rheumatological endpoints

100

515

1.11

0.42

2.0

1.9

2.32

3.71

ug/l

0.67

321

Colorectal adenocarcinoma

131

1.30

0.42

1.1

1.8

2.62

2.27

ug/l

—

Benign neoplasm: Ascending colon

1.36

0.41

1.2

2.1

2.71

2.13

ug/l

—

Vertigo of central origin

0.00

0.41

0.0

1.9

—

2.37

—

Benign neoplasm: Other and unspecified parts of small intestine

0.00

0.41

0.0

2.4

—

2.37

—

Orthopaedic devices associated with adverse incidents

0.00

0.41

0.0

1.9

—

2.76

—

Motor neuron disease

0.00

0.41

0.0

1.1

—

0.98

—

Motor neuron disease (with DMD)

0.00

0.41

0.0

1.1

—

0.98

—

Fourth [trochlear] nerve palsy

0.00

0.41

0.0

1.1

—

1.08

—

Paraplegia, diplegia of upper limbs

0.00

0.41

0.0

1.9

—

1.98

—

Other and unspecified degenerative diseases of nervous system

0.00

0.41

0.0

2.4

—

2.13

—

Urethritis and urethral syndrome

0.00

0.41

0.0

2.3

—

2.83

—

Bicuspidal aortic valve syndrome

0.00

0.41

0.0

1.9

—

2.13

—

Tooth agenesis EXCLUDE clefts and syndromes

0.00

0.41

0.0

2.4

—

3.35

—

L02BX Other hormone antagonists and related agents

0.00

0.41

0.0

1.0

—

1.29

—

Drug-induced osteoporosis with pathological fracture

0.00

0.41

0.0

2.3

—

2.11

—

Other overlap syndromes

0.00

0.41

0.0

1.9

—

2.30

—

Other disorders of breast and lactation associated with childbirth

0.00

0.41

0.0

2.3

—

3.00

—

Respiratory conditions due to other external agents

0.00

0.41

0.0

1.8

—

2.19

—

Bullous pemphigoid

0.00

0.41

0.0

2.3

—

2.43

—

0.00

0.41

0.0

2.0

—

2.30

—

Acquired haemolytic anaemia

0.00

0.41

0.0

1.8

—

2.19

—

Other and unspecified diseases of blood and blood-forming organs

0.00

0.41

0.0

1.1

—

1.08

—

Superficial injuries involving multiple body regions

0.00

0.41

0.0

1.8

—

2.37

—

Other specified disorders of external ear

0.00

0.41

0.0

1.8

—

2.15

—

Spinal enthesopathy

0.00

0.41

0.0

2.4

—

3.08

—

Other arthritis (FG)

261

0.80

0.41

1.7

1.8

1.87

3.27

ug/l

0.64

155

Peroneal tendinitis

0.00

0.40

0.0

2.3

—

2.80

—

Disorders of oesophagus in diseases classified elsewhere

0.00

0.40

0.0

2.4

—

2.64

—

Endocrine disorders, other/unspecified

0.00

0.40

0.0

1.9

—

2.56

—

Other specific arthropathies, wide

0.00

0.40

0.0

2.4

—

1.86

—

therapeutic use

0.00

0.40

0.0

1.9

—

2.75

—

Use of levodopa decarbox-comt-inhibitor

0.00

0.40

0.0

1.8

—

2.20

—

Malignant neoplasm of liver and intrahepatic bile ducts

0.00

0.40

0.0

1.8

—

2.33

—

Problems related to social environment

0.00

0.40

0.0

2.2

—

2.56

—

Brachial plexus disorders

1.39

0.40

1.0

1.9

2.24

1.76

ug/l

—

Episodal and paroxysmal disorders

100

565

0.91

0.40

1.6

1.9

2.23

3.64

ug/l

0.69

348

Insulin medication

380

0.85

0.40

1.9

1.7

2.50

2.99

ug/l

0.19

220

Hypertensive Heart Disease

113

0.72

0.40

1.4

1.5

1.60

2.31

ug/l

—

Allergic contact dermatitis due to drugs in contact with skin

0.00

0.40

0.0

1.8

—

2.19

—

Immunodeficiency with predominantly antibody defects

0.00

0.40

0.0

2.2

—

2.69

—

Malignant neoplasm of brain

0.00

0.40

0.0

1.8

—

2.05

—

Pedal cyclist injured in collision with motor vehicle

0.00

0.40

0.0

1.8

—

2.19

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

0.00

0.40

0.0

2.2

—

2.29

—

Mental and behavioural disorders due to opioids

0.00

0.40

0.0

1.8

—

2.70

—

Varicose veins

414

1.13

0.39

1.6

1.8

2.94

2.72

ug/l

0.09

250

Diabetes mellitus

105

570

1.10

0.39

1.7

1.8

2.13

3.65

ug/l

0.86

347

Coxarthrosis, primary, with hip surgery

316

1.17

0.39

1.6

1.7

3.24

2.35

ug/l

0.28

182

Any mental disorder

103

567

0.91

0.39

2.4

1.7

1.90

3.76

ug/l

1.15

345

Other antidepressants

105

498

1.10

0.39

1.8

1.7

1.72

3.97

ug/l

1.39

314

Ovarian hyperstimulation (induction)

0.00

0.39

0.0

2.2

—

2.46

—

Venous complications and haemorrhoids in pregnancy

0.00

0.39

0.0

2.1

—

2.13

—

Benign neoplasm: Liver

0.00

0.39

0.0

1.7

—

2.11

—

Multiple myeloma

0.00

0.39

0.0

2.1

—

2.27

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

0.00

0.39

0.0

2.1

—

2.27

—

Adenocarcinoma of pancreas

0.00

0.39

0.0

1.8

—

2.15

—

Hyperaldosteronism

0.00

0.39

0.0

2.1

—

2.12

—

Major anomalies of jaw size

0.00

0.39

0.0

1.8

—

2.04

—

Adenocarcinoma and ductal carcinoma of pancreas

0.00

0.39

0.0

1.8

—

2.15

—

Preparatory care for dialysis

0.00

0.39

0.0

1.7

—

2.36

—

Hallux valgus (acquired)

251

0.84

0.39

1.8

2.1

2.73

3.16

ug/l

0.13

160

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

537

0.90

0.39

1.5

1.8

2.37

3.76

ug/l

0.62

329

537

0.90

0.39

1.5

1.8

2.37

3.76

ug/l

0.62

329

Other disorders starting during childhood or adolescence

0.00

0.39

0.0

2.4

—

2.91

—

Superficial injury of lower leg

204

0.78

0.39

1.3

1.9

2.22

2.26

ug/l

0.02

113

Codeine or tramadol medication

116

588

1.09

0.38

1.8

1.7

6.96

2.56

ug/l

0.56

354

Focal epilepsy

148

0.74

0.38

1.1

1.7

1.85

1.92

ug/l

—

Abrasion of teeth

157

1.22

0.38

1.7

2.2

1.46

2.15

ug/l

1.39

Fibroblastic disorders

169

1.24

0.38

2.1

1.8

2.01

2.23

ug/l

0.16

Dental caries 2, only avohilmo

546

1.11

0.38

1.5

1.9

1.69

3.58

ug/l

1.14

330

Visual disturbances

409

0.86

0.38

2.3

1.8

1.58

2.96

ug/l

1.12

243

Gonarthrosis

315

1.13

0.37

1.5

2.0

2.52

2.96

ug/l

0.18

197

Gastro-oesophageal reflux disease

513

0.88

0.37

1.9

2.09

2.93

ug/l

0.64

316

Diarrhoea and gastroenteritis of presumed infectious origin

526

0.88

0.37

1.6

1.8

2.61

3.75

ug/l

0.45

315

Other embolism and thrombosis

1.33

0.37

1.1

2.0

5.18

2.10

ug/l

—

Malaise and fatigue

314

0.85

0.37

2.1

1.8

1.71

3.21

ug/l

0.99

189

Open wound of head

360

0.85

0.37

1.1

1.6

2.28

2.35

ug/l

0.07

204

Acute generalized exanthematous pustulosis

1.35

0.37

1.2

2.0

—

1.97

—

Acute suppurative otitis media

167

1.23

0.37

2.3

1.9

2.77

4.09

ug/l

0.33

Cardiomyopathy

107

1.31

0.37

1.1

1.7

2.39

2.48

ug/l

—

Benign paroxysmal vertigo

246

0.81

0.36

1.2

1.8

1.88

2.37

ug/l

0.46

137

Statin medication

367

1.12

0.36

1.3

2.0

1.97

4.61

ug/l

1.05

222

Persons encountering health services in other circumstances

299

1.17

0.36

2.5

1.5

2.97

2.08

ug/l

0.48

175

Other arthrosis

307

1.14

0.36

1.7

2.0

2.45

3.02

ug/l

0.24

191

Dental pulpitis 1, only avohilmo

549

0.91

0.36

1.8

2.05

3.80

ug/l

0.89

323

Other systemic involvement of connective tissue

245

0.82

0.35

1.7

1.9

1.35

3.45

ug/l

1.11

139

Family history of malignant neoplasm

1.33

0.35

1.0

1.9

1.86

2.12

ug/l

—

Diseases of middle ear and mastoid

403

0.87

0.35

2.1

1.7

2.17

2.96

ug/l

0.50

231

Insulin, intermediate and long-acting

388

0.86

0.35

1.6

1.7

2.62

2.93

ug/l

0.11

211

Benign neoplasm of other and unspecified endocrine glands

1.31

0.35

2.1

1.8

3.47

1.95

ug/l

—

Primary_lymphoid and hematopoietic malignant neoplasms

162

1.23

0.35

1.5

1.9

2.02

2.15

ug/l

—

Disorders of refraction and accommodation

211

0.80

0.35

1.8

1.9

1.46

3.60

ug/l

—

119

Pain and other conditions associated with female genital organs and menstrual cycle

138

1.25

0.35

1.8

2.4

1.26

2.50

ug/l

—

Benign neoplasm: Rectum

126

1.27

0.35

1.0

1.9

1.38

2.14

ug/l

—

Gestational [pregnancy-induced] hypertension

287

0.83

0.35

1.8

2.1

2.31

5.06

ug/l

0.74

172

Other and unspecified iron deficiency

255

0.82

0.35

1.7

1.98

2.34

ug/l

—

138

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

457

0.88

0.34

1.6

2.1

1.85

3.81

ug/l

0.95

287

Chronic diseases of tonsils and adenoids

490

1.10

0.33

1.8

2.61

3.76

ug/l

0.45

312

Benign neoplasm: Rectum, anus and anal canal

145

1.24

0.33

1.0

1.8

1.38

2.29

ug/l

—

Diseases of oral cavity, salivary glands and jaws

441

1.09

0.33

1.3

1.8

1.56

3.57

ug/l

1.15

271

Dental pulpitis 4, only avohilmo

546

0.92

0.33

1.8

2.04

3.81

ug/l

0.90

321

Cutaneous abscess, furuncle and carbuncle

188

0.80

0.33

3.3

1.7

2.51

2.06

ug/l

0.30

105

Obstructed labour due to maternal pelvic abnormality

166

0.78

0.33

1.8

2.2

1.71

3.92

ug/l

—

Malignant neoplasm of breast, HER2-negative

398

0.89

0.33

1.4

2.0

13.53

3.12

ug/l

0.41

250

Other problems related to primary support group, including family circumstances

0.68

0.33

1.0

1.9

1.82

1.70

ug/l

—

Visual disturbances and blindness

424

0.87

0.32

2.2

1.8

1.58

2.98

ug/l

1.24

254

Asthma (mode)

431

1.10

0.32

1.6

1.8

2.26

4.05

ug/l

0.74

267

Diabetes, insulin treatment (Kela reimbursement)

551

1.09

0.32

1.6

1.9

2.35

2.87

ug/l

0.37

326

Colorectal cancer

155

1.23

0.32

1.1

1.8

2.46

2.17

ug/l

—

Transport accidents

366

0.87

0.32

1.6

1.8

1.94

2.81

ug/l

0.45

222

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

128

1.25

0.31

1.1

1.8

1.25

1.96

ug/l

1.73

Cervicocranial syndrome

1.31

0.31

2.3

1.77

2.24

ug/l

—

Urticaria

262

0.84

0.31

1.4

2.0

3.59

3.35

ug/l

0.05

151

Other soft tissue disorders, not elsewhere classified

487

1.09

0.31

2.0

1.8

9.41

2.79

ug/l

0.52

303

Noninfectious colitis NAS

0.72

0.30

1.1

1.9

4.21

2.04

ug/l

—

Other noninflammatory disorders of uterus, except cervix

131

1.20

0.30

1.6

2.0

1.58

2.74

ug/l

1.72

Haemorrhage in early pregnancy

318

0.86

0.30

2.0

2.1

2.10

4.56

ug/l

0.79

197

Sleep disorders

164

0.79

0.30

1.1

1.8

1.27

2.06

ug/l

—

Lumbar disc prolapse

430

1.11

0.30

1.5

1.9

12.84

2.87

ug/l

0.43

266

All-cause Heart Failure

281

0.87

0.30

1.1

1.6

2.95

2.21

ug/l

0.37

155

Sulfonylureas

183

0.83

0.30

1.5

3.58

2.19

ug/l

0.44

Injuries to the knee and lower leg

103

636

0.93

0.30

1.5

1.8

2.89

3.41

ug/l

0.21

387

Other extrapyramidal and movement disorders in other diseases

174

0.80

0.29

1.1

1.9

1.97

2.12

ug/l

—

Anxiety disorders, excluding more controls

550

1.08

0.29

2.1

1.7

1.55

3.78

ug/l

1.51

335

Asthma

429

1.09

0.29

1.6

1.8

2.30

4.06

ug/l

0.72

266

Noninfective enteritis and colitis

372

1.13

0.29

1.6

1.8

1.94

2.96

ug/l

0.55

212

Dental operations

312

1.10

0.29

1.4

1.6

1.84

4.21

ug/l

0.86

190

Coagulation defects, purpura and other haemorrhagic conditions

148

1.22

0.29

2.0

1.6

4.46

1.78

ug/l

0.61

Disorders of eyelid, lacrimal system and orbit

584

1.09

0.29

1.5

1.8

2.17

2.82

ug/l

0.51

356

Rheumatoid arthritis, including avohilmo

345

0.87

0.29

1.3

1.9

4.38

3.11

ug/l

0.25

200

Dental caries 2

555

1.09

0.29

1.5

1.9

1.69

3.54

ug/l

1.14

337

Maternal care related to the fetus and amniotic cavity and possible delivery problems

297

0.89

0.28

1.7

2.3

1.81

3.98

ug/l

0.75

189

Atopic dermatitis, strict definition with reimbursement

234

1.16

0.28

1.5

2.0

3.18

2.14

ug/l

0.59

144

Other systemic involvement of connective tissue (FG)

236

0.84

0.28

1.7

1.8

1.35

3.45

ug/l

1.10

139

Infective dermatitis

1.32

0.28

1.9

1.8

2.78

2.00

ug/l

—

Degeneration of macula and posterior pole

284

0.87

0.28

1.6

1.8

1.73

2.63

ug/l

1.68

163

Missing teeth due to accident, extraction or parodontitis

1.28

0.28

1.6

2.4

1.13

2.16

ug/l

—

Delivery, wide proxy

218

1.12

0.28

2.0

2.36

2.92

ug/l

0.47

134

Other and unspecified disorders of vitreous body

363

0.88

0.28

1.8

2.38

2.43

ug/l

0.04

217

Subjective visual disturbances

205

0.83

0.28

2.3

1.8

1.22

2.33

ug/l

—

110

Specific personality disorders

186

1.18

0.27

2.5

1.8

2.61

3.58

ug/l

0.25

105

Dental caries 1 and operation codes, only avohilmo

116

1.17

0.27

1.1

2.5

1.42

4.79

ug/l

0.79

Heart failure and antihypertensive medication

104

1.21

0.27

1.2

1.7

2.49

3.33

ug/l

0.59

Cervical disc disorders

290

0.86

0.27

1.1

1.8

1.52

3.11

ug/l

1.00

178

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

527

1.08

0.26

1.6

1.9

2.33

3.80

ug/l

0.69

315

Tinnitus

193

0.83

0.26

1.5

1.8

38.16

2.25

ug/l

—

101

Monoamine oxidase A inhibitors

104

1.25

0.26

1.5

2.1

1.48

2.39

ug/l

—

Fracture of forearm

458

0.90

0.26

1.7

1.8

1.75

2.94

ug/l

1.22

285

Palmar fascial fibromatosis [Dupuytren]

1.28

0.26

1.9

1.6

2.67

1.96

ug/l

—

Dental caries 3 and operation codes, only avohilmo

145

1.14

0.26

1.2

2.3

1.33

4.17

ug/l

0.88

Cardiomyopathy (excluding other)

1.30

0.26

1.0

1.7

2.58

2.29

ug/l

—

Preterm labour and delivery

278

0.86

0.26

2.1

2.2

2.31

3.27

ug/l

0.37

166

Triptan medication for migraine, single purchase ok

529

0.92

0.26

1.6

2.0

1.53

3.68

ug/l

1.40

328

Migraine, single triptan purchase ok & required. ICD-code if available is included

529

0.92

0.26

1.6

2.0

1.53

3.68

ug/l

1.40

328

Type of accident

214

0.84

0.26

1.2

1.8

1.61

2.34

ug/l

—

114

Coxarthrosis [arthrosis of hip](FG)

320

1.11

0.25

1.4

1.8

2.11

2.29

ug/l

0.17

189

Retained placenta and membranes, without haemorrhage

138

0.80

0.25

2.3

1.9

1.93

4.34

ug/l

—

Other anxiety disorders

358

0.89

0.25

1.9

1.61

3.03

ug/l

1.12

216

Asthma/COPD (KELA code 203)

611

1.07

0.25

1.5

1.9

1.92

3.57

ug/l

1.07

373

Dental caries 2 and operation codes

551

1.08

0.25

1.5

1.9

1.70

3.56

ug/l

1.13

334

Dental operations, only avohilmo

335

1.09

0.24

1.5

1.8

1.81

4.93

ug/l

1.20

205

Obesity due to excess calories

392

0.89

0.24

1.4

2.0

2.04

2.91

ug/l

0.52

228

Coxarthrosis

269

1.11

0.24

1.4

2.0

2.26

2.03

ug/l

0.21

163

Ischaemic heart disease, wide definition

409

0.92

0.24

1.9

1.7

1.94

2.43

ug/l

0.93

245

Influenza and pneumonia

640

0.93

0.23

1.8

2.47

3.47

ug/l

0.49

389

Neurological diseases, wide definition

151

1.13

0.23

1.1

2.1

1.27

3.77

ug/l

0.89

100

Nonorganic sleeping disorders, excluding more controls

147

0.82

0.23

1.1

1.7

1.27

2.03

ug/l

—

Early onset COPD

147

0.82

0.23

1.5

1.6

4.30

2.20

ug/l

—

Asthma, excluding more controls

417

1.07

0.23

1.5

1.8

2.36

4.04

ug/l

0.65

258

Exposure to unspecified factor

657

0.93

0.22

1.5

1.8

9.56

2.67

ug/l

0.51

405

Benzodiazepine use

634

1.07

0.22

1.9

1.8

2.20

3.55

ug/l

0.81

381

Implicit bacterial Sepsis

235

1.13

0.22

2.1

1.5

4.08

2.34

ug/l

0.55

136

Major coronary heart disease event excluding revascularizations

327

0.91

0.22

1.3

1.7

2.77

2.51

ug/l

0.14

187

Disorders of conjunctiva

625

1.07

0.22

1.6

1.8

2.60

3.47

ug/l

0.43

383

Other pulmonary diagnosis

436

1.07

0.22

1.6

1.8

2.25

4.01

ug/l

0.73

271

Valvular heart disease excluding rheumatic fever

262

0.89

0.22

1.7

1.9

2.10

2.62

ug/l

0.53

151

Other shoulder lesions

1.27

0.22

1.1

2.1

1.40

1.99

ug/l

—

All influenza

178

0.84

0.22

3.5

1.6

2.56

2.16

ug/l

—

Dental caries 3

401

1.07

0.21

1.3

1.8

1.61

2.54

ug/l

3.09

237

Pregnancy hypertension

416

0.91

0.21

1.6

2.2

1.86

3.97

ug/l

0.95

264

Non-rheumatic valve diseases

261

0.89

0.21

1.7

1.9

2.10

2.62

ug/l

0.53

151

Other specified and unspecified disorders of conjunctiva

0.00

0.21

0.0

2.3

—

2.76

—

Foreign body in genitourinary tract

0.00

0.21

0.0

2.3

—

2.80

—

Cerebral atherosclerosis

0.00

0.21

0.0

3.0

—

2.82

—

Benign neoplasm: Parathyroid gland

0.00

0.21

0.0

2.1

—

2.88

—

Epidural haemorrhage

0.00

0.21

0.0

2.1

—

2.76

—

Gastrointestinal stromal tumor and sarcoma

0.00

0.21

0.0

1.1

—

1.08

—

Venous complications and haemorrhoids in the puerperium

0.00

0.21

0.0

2.3

—

2.44

—

Benign neoplasm: Connective and other soft tissue, unspecified

0.00

0.21

0.0

2.3

—

2.54

—

Calcaneal spur

0.00

0.21

0.0

2.2

—

2.78

—

Arthropathy in ulcerative colitis

0.00

0.21

0.0

2.3

—

2.70

—

Hereditary ataxia

0.00

0.21

0.0

2.3

—

2.76

—

Hyperosmolality and hypernatraemia

0.00

0.21

0.0

2.8

—

2.63

—

Contracture of joint

0.00

0.21

0.0

2.2

—

2.50

—

Nystagmus and other irregular eye movements

0.00

0.21

0.0

2.4

—

2.72

—

Other degenerative diseases of the basal ganglia

0.00

0.21

0.0

2.2

—

2.58

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

0.00

0.21

0.0

2.2

—

2.74

—

Toxic liver disease

0.00

0.21

0.0

2.2

—

2.72

—

Infection due to other mycobacteria

0.00

0.21

0.0

1.1

—

0.86

—

Congenital malformations of breast

0.00

0.21

0.0

2.4

—

2.70

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

0.00

0.21

0.0

2.3

—

2.54

—

Hypothermia

0.00

0.21

0.0

2.2

—

2.58

—

Acute myeloid leukaemia and myelodysplastic syndromes

0.00

0.21

0.0

3.0

—

2.82

—

Contact with lifting and transmission devices, not elsewhere classified

0.00

0.21

0.0

2.3

—

2.58

—

Schizoid personality disorder

0.00

0.21

0.0

2.3

—

2.76

—

Acidosis

0.00

0.21

0.0

3.0

—

2.78

—

Complications associated with artificial fertilization

0.00

0.21

0.0

1.3

—

1.84

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

0.00

0.21

0.0

3.0

—

2.82

—

Open wound of shoulder and upper arm

0.00

0.21

0.0

3.1

—

2.48

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

0.00

0.21

0.0

2.2

—

2.76

—

Motorcycle rider injured in noncollision transport accidents

0.00

0.21

0.0

2.1

—

2.74

—

Rubella [German measles]

0.00

0.21

0.0

2.2

—

2.86

—

TMD related operations

135

1.19

0.21

1.8

1.7

1.10

2.20

ug/l

2.73

Procreative management

217

1.13

0.21

1.9

2.0

1.58

3.79

ug/l

1.13

137

Benign neoplasm: Oesophagus

0.00

0.21

0.0

2.1

—

2.37

—

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

0.00

0.21

0.0

1.6

—

2.32

—

Malignant neoplasm of other and unspecified parts of biliary tract

0.00

0.21

0.0

2.1

—

2.37

—

Malignant neoplasm of other and unspecified parts of tongue

0.00

0.21

0.0

2.1

—

2.37

—

Other disorders of choroid

0.00

0.21

0.0

2.8

—

2.84

—

Guttate psoriasis

0.00

0.21

0.0

2.2

—

2.42

—

Laparoscopic left hemicolectomy

0.00

0.21

0.0

2.0

—

2.74

—

Use of amantadine

0.00

0.21

0.0

2.1

—

2.78

—

Asthma, unspecified (mode), excluding more controls

390

1.09

0.21

1.7

1.8

2.47

4.18

ug/l

0.60

243

Charcot foot

0.00

0.21

0.0

2.1

—

2.78

—

Helminthiases

0.00

0.21

0.0

2.1

—

2.54

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

0.00

0.21

0.0

2.1

—

2.54

—

Certain zoonotic bacterial diseases

0.00

0.21

0.0

2.1

—

2.37

—

Circumscribed brain atrophy

0.00

0.21

0.0

2.1

—

2.33

—

Need for immunization against other single viral diseases

0.00

0.21

0.0

2.0

—

2.74

—

Background retinopathy and retinal vascular changes

0.00

0.21

0.0

2.7

—

2.96

—

Sequelae of tuberculosis

0.00

0.21

0.0

1.7

—

1.44

—

Exposure to smoke, fire and flames

0.00

0.21

0.0

2.1

—

2.37

—

Generalized epilepsy, strict definition

0.00

0.21

0.0

2.3

—

2.64

—

Embolic stroke with flimmer

0.00

0.21

0.0

1.9

—

1.44

—

Psoriasis

220

1.14

0.21

1.4

1.9

1.95

2.20

ug/l

0.25

119

Spinal stenosis

304

0.90

0.21

1.4

1.8

1.79

2.31

ug/l

1.30

185

Diseases caused by chlamydiae

0.00

0.21

0.0

2.2

—

2.43

—

Other diseases caused by chlamydiae

0.00

0.21

0.0

2.2

—

2.43

—

CR(E)ST syndrome

0.00

0.21

0.0

2.5

—

2.54

—

Benign neoplasm: Short bones of upper limb

0.00

0.21

0.0

2.1

—

2.39

—

Other crystal arthropathies

0.00

0.21

0.0

2.8

—

2.40

—

Malignant neoplasm of tongue

0.00

0.21

0.0

2.0

—

2.37

—

Malnutrition

0.00

0.21

0.0

2.0

—

2.40

—

Respiratory tuberculosis, confirmed

0.00

0.21

0.0

2.0

—

2.33

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

0.00

0.21

0.0

2.0

—

2.33

—

Dementia due to Parkinson's disease

0.00

0.21

0.0

1.6

—

1.58

—

Syphilis

0.00

0.21

0.0

2.0

—

2.58

—

Injury of intra-abdominal organs

0.00

0.21

0.0

2.0

—

2.19

—

Deforming dorsopathies

249

1.12

0.20

1.6

1.8

2.91

3.25

ug/l

0.09

152

Angina pectoris

318

0.91

0.20

1.3

1.7

2.02

2.65

ug/l

0.97

185

Neurological diseases

456

0.94

0.20

1.7

2.0

2.33

3.80

ug/l

0.62

287

Carcinoma in situ of breast, other/unspecified

0.00

0.20

0.0

2.5

—

2.68

—

Other specified and unspecified disorders of eyelid

0.00

0.20

0.0

1.9

—

2.19

—

Other and unspecified hydrocephalus

0.00

0.20

0.0

1.9

—

2.18

—

Dementia due to Parkinsons disease, excluding more controls

0.00

0.20

0.0

1.1

—

1.26

—

Retinal haemorrhage

0.00

0.20

0.0

2.5

—

2.84

—

Adenocarcinoma and papillary adenocarcinoma of stomach

0.00

0.20

0.0

2.5

—

2.27

—

Vascular dementia (subcortical)

0.00

0.20

0.0

1.6

—

2.86

—

Other, unspecified and serous retinal detachments

0.00

0.20

0.0

1.9

—

2.65

—

Burn and corrosion of trunk

0.00

0.20

0.0

1.9

—

2.37

—

Suppurative otitis media, unspecified

0.00

0.20

0.0

1.9

—

2.37

—

Amputation of thigh

0.00

0.20

0.0

2.4

—

2.67

—

Disorders of sclera, cornea, iris and ciliary body

441

1.09

0.20

1.5

1.9

3.06

2.81

ug/l

0.08

265

Striking against or struck by other objects

208

0.86

0.20

1.4

1.7

1.67

2.02

ug/l

0.57

115

Adenomyosis (Endometriosis of uterus)

108

1.20

0.20

1.5

2.0

1.66

2.75

ug/l

—

Other disorders of fluid, electrolyte and acid-base balance

204

1.13

0.20

2.6

1.4

3.47

2.24

ug/l

0.54

105

Early onset COPD, excluding more controls

144

0.83

0.20

1.5

1.7

4.30

2.29

ug/l

—

Nonorganic sleeping disorders

144

0.83

0.19

1.1

1.9

1.27

2.13

ug/l

—

Abnormal findings on examination of blood, without diagnosis

273

0.89

0.19

1.3

1.6

1.67

2.36

ug/l

1.22

143

Iron deficiency anaemia

330

0.90

0.19

1.9

1.7

11.02

2.43

ug/l

0.45

188

Heart failure, strict

285

0.91

0.19

1.1

1.6

3.11

2.36

ug/l

0.38

157

Antenatal screening

135

0.88

0.19

2.0

2.4

2.40

4.24

ug/l

0.47

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

203

1.13

0.19

1.1

1.7

1.98

2.00

ug/l

0.01

105

COPD/asthma/ILD related infections

113

537

1.05

0.19

1.9

1.8

2.28

3.76

ug/l

0.72

329

COPD/asthma related infections

113

537

1.05

0.19

1.9

1.8

2.28

3.76

ug/l

0.72

329

Polyneuropathies and other disorders of the peripheral nervous system

137

1.17

0.18

2.9

1.8

3.08

2.04

ug/l

—

Type 2 diabetes, wide definition

427

1.07

0.18

1.5

1.8

2.70

3.07

ug/l

0.19

251

Dyspnoea

587

0.94

0.18

1.7

1.8

2.53

2.75

ug/l

0.12

358

Obesity and other hyperalimentation

544

0.93

0.18

1.6

1.9

1.97

3.62

ug/l

0.89

322

Codes for special purposes

363

0.91

0.18

1.7

1.9

3.08

2.91

ug/l

0.04

212

Fracture of shoulder and upper arm

269

0.89

0.18

1.6

1.8

2.38

2.23

ug/l

0.16

154

Focal epilepsy, strict definition

132

0.83

0.18

1.1

1.7

1.85

1.99

ug/l

—

Malignant neoplasm of digestive organs

238

1.12

0.18

1.0

1.6

2.88

2.45

ug/l

0.16

131

Disorders of vitreous body

416

0.92

0.18

1.8

2.39

2.34

ug/l

0.05

246

Asthma, including avohilmo

112

619

1.05

0.18

1.5

1.9

2.30

3.54

ug/l

0.71

380

Diseases of the digestive system

318

1.10

0.18

1.8

1.6

1.80

2.25

ug/l

0.68

176

Calcific aortic valvular stenosis, including rheumatic fever

160

0.86

0.18

1.5

1.6

2.91

2.23

ug/l

—

Mood disorders, excluding more controls

566

0.95

0.18

2.1

1.7

1.77

3.77

ug/l

1.31

344

Obesity, other/unspecified

300

0.90

0.18

1.7

2.1

2.30

3.15

ug/l

0.38

179

Glaucoma suspect

279

0.90

0.17

1.5

1.9

2.29

2.50

ug/l

0.07

156

Disorders of lacrimal system

377

1.09

0.17

1.2

1.9

1.74

2.98

ug/l

0.98

228

Macular pucker

119

1.18

0.17

1.3

1.9

1.90

2.11

ug/l

—

Obesity

543

0.93

0.17

1.6

1.9

1.97

3.63

ug/l

0.88

321

Provisional assignment of new diseases of uncertain etiology

362

0.91

0.17

1.7

1.9

3.08

2.91

ug/l

0.04

212

Other viral diseases, not elsewhere classified

131

0.84

0.17

2.5

1.7

2.00

2.03

ug/l

—

Migraine

440

0.93

0.17

1.6

2.0

1.33

3.76

ug/l

1.30

275

Other gastritis (incl. Duodenitis)

176

1.14

0.17

1.1

1.8

1.44

2.49

ug/l

—

Malignant neoplasm of breast

403

0.93

0.17

1.3

2.0

13.05

3.10

ug/l

0.41

253

Acute sinusitis

415

1.08

0.17

1.7

1.9

2.00

4.05

ug/l

0.87

257

Non-ischemic cardiomyopathy

177

0.88

0.17

1.3

1.5

4.32

2.19

ug/l

0.59

102

Disorders of mineral metabolism

0.76

0.17

3.4

1.7

2.14

1.97

ug/l

—

Acute upper respiratory infections of multiple and unspecified sites

479

1.06

0.17

1.6

1.8

1.88

3.84

ug/l

1.00

293

Effects of foreign body entering through natural orifice

152

0.86

0.16

1.0

1.6

2.75

1.93

ug/l

—

Non-selective monoamine reuptake inhibitors

330

0.91

0.16

1.1

1.8

1.43

3.38

ug/l

1.58

203

Pedal cyclist injured in noncollision transport accidents

0.71

0.16

2.0

1.7

1.26

1.80

ug/l

—

Accidents

465

0.95

0.16

1.5

1.8

2.34

2.82

ug/l

0.29

285

Operations 2 for CAVS

159

0.86

0.16

1.5

1.6

2.91

2.15

ug/l

—

Calcific aortic valvular stenosis, diagnosis (helper)

159

0.86

0.16

1.5

1.6

2.91

2.15

ug/l

—

Calcific aortic valvular stenosis

159

0.86

0.16

1.5

1.6

2.91

2.15

ug/l

—

Calcific aortic valvular stenosis, operated

159

0.86

0.16

1.5

1.6

2.91

2.15

ug/l

—

Dysphagia

173

0.87

0.16

1.5

1.6

1.69

2.23

ug/l

—

102

Anomalies of dental arch relationship, including avohilmo

127

0.85

0.16

2.7

1.9

1.59

2.06

ug/l

—

Osteoporosis with pathological fracture (FG)

1.14

0.16

6.6

1.6

3.62

2.36

ug/l

—

Bronchitis

634

0.95

0.16

2.2

1.7

1.89

3.54

ug/l

1.18

392

Mood disorders

635

0.95

0.16

2.3

1.7

2.02

3.54

ug/l

1.02

392

Asthma, unspecified (mode)

400

1.07

0.16

1.7

1.8

2.47

4.20

ug/l

0.63

250

Other specific joint derangements/joint disorders

436

1.06

0.16

1.3

2.0

2.22

3.82

ug/l

0.67

281

Ischemic heart diseases

413

0.94

0.16

1.9

1.7

1.91

2.43

ug/l

1.01

246

Dental caries 3, only avohilmo

412

1.06

0.16

1.3

1.8

1.61

2.53

ug/l

3.14

245

Pre-eclampsia or eclampsia

235

0.89

0.16

1.3

2.2

1.45

3.58

ug/l

1.06

137

Polyarthrosis

170

1.13

0.15

1.5

2.1

1.81

2.12

ug/l

—

110

Pollen allergy

139

0.85

0.15

1.2

1.8

1.86

2.00

ug/l

—

Other heart diseases

263

1.08

0.15

1.4

1.8

1.60

2.13

ug/l

0.90

152

Selective serotonin reuptake inhibitors

498

0.95

0.15

2.0

1.7

1.72

3.97

ug/l

1.39

314

Maternal care for known or suspected abnormality of pelvic organs

191

0.90

0.15

1.5

2.1

1.67

4.95

ug/l

0.75

123

Parodontitis and operation codes

575

0.95

0.15

2.0

1.8

2.56

2.78

ug/l

0.10

343

Coronary atherosclerosis

345

0.93

0.15

2.1

1.7

1.94

2.59

ug/l

1.13

203

Presence of cardiac and vascular implants and grafts

217

0.91

0.15

1.5

1.6

2.12

2.34

ug/l

0.24

120

Other disorders of patella

161

0.87

0.15

1.6

2.1

1.31

3.89

ug/l

—

Disorders of adult personality and behaviour

226

1.11

0.15

2.3

1.7

2.54

3.56

ug/l

0.33

132

Hard cardiovascular diseases

422

0.94

0.15

1.8

1.7

1.96

2.34

ug/l

0.65

250

Mood [affective] disorders

634

0.95

0.15

2.3

1.7

2.02

3.55

ug/l

1.03

391

Other disorders of teeth and supporting structures

169

1.12

0.14

1.5

2.0

2.81

2.33

ug/l

—

Heart failure, not strict

424

0.94

0.14

1.5

1.8

2.47

2.31

ug/l

0.17

252

Other noninfective gastroenteritis and colitis

191

0.89

0.14

1.6

1.8

3.04

2.32

ug/l

0.25

Plantar fascial fibromatosis

1.19

0.14

2.3

2.1

1.22

2.45

ug/l

—

Reimbursement for rheumatic diseases

520

0.94

0.14

1.4

1.8

3.35

2.77

ug/l

0.19

308

Chronic rhinitis, nasopharyngitis and pharyngitis

274

0.91

0.13

2.6

1.9

1.24

3.11

ug/l

1.28

174

Symptoms and signs involving the urinary system

482

0.95

0.13

2.1

1.7

1.87

3.05

ug/l

0.96

281

Covid-19 suspected case

170

1.12

0.13

1.5

1.8

4.08

3.86

ug/l

0.03

Atrial fibrillation and flutter with reimbursement

127

1.11

0.13

2.6

1.7

1.72

2.55

ug/l

0.89

Strabismus

211

0.90

0.13

1.7

1.8

4.10

2.19

ug/l

—

114

Syncope and collapse

288

0.92

0.13

1.5

1.7

1.59

3.32

ug/l

1.05

165

Postmenopausal atrophic vaginitis

140

0.90

0.13

1.3

2.1

2.01

2.82

ug/l

0.73

Bipolar affective disorders

159

0.88

0.13

1.9

1.7

2.22

2.27

ug/l

—

Inguinal hernia

268

0.93

0.13

1.1

1.5

2.36

2.19

ug/l

0.10

148

Glomerular diseases

113

1.15

0.13

1.4

1.8

1.88

1.96

ug/l

—

Arthrosis

355

1.05

0.13

1.7

2.0

2.80

4.22

ug/l

0.41

222

Coronary angioplasty

194

0.91

0.13

1.3

1.5

2.00

2.40

ug/l

0.28

108

Other hammer toe(s) (acquired)

151

1.12

0.12

1.5

2.1

2.71

2.20

ug/l

—

Other symptoms and signs involving cognitive functions and awareness

304

0.93

0.12

1.6

1.8

1.59

2.30

ug/l

2.39

171

Other disorders of bone

148

0.88

0.12

1.9

1.6

1.30

1.93

ug/l

—

Pre-eclampsia or poor fetal growth

323

0.93

0.12

1.4

2.1

8.71

2.36

ug/l

0.40

198

Other external causes of accidental injury

465

0.96

0.12

1.4

1.8

2.35

2.82

ug/l

0.28

285

Postpartum haemorrhage

228

0.92

0.12

2.6

1.9

2.81

5.69

ug/l

0.57

140

106

581

0.96

0.12

2.0

1.8

1.69

3.70

ug/l

1.42

360

Hyperplasia of prostate

1.14

0.12

1.0

1.66

2.17

ug/l

—

Other menopausal disorders

143

1.09

0.11

1.5

2.1

1.08

2.72

ug/l

3.46

Symptoms and signs involving the circulatory and respiratory systems

106

512

1.04

0.11

2.2

1.8

1.87

3.79

ug/l

1.08

319

Superficial injury of hip and thigh

1.16

0.11

1.3

1.7

6.62

2.45

ug/l

—

Other disorders of ear

542

0.96

0.11

2.2

1.7

8.06

2.84

ug/l

0.39

322

Female genital prolapse

149

1.08

0.11

2.1

1.24

2.73

ug/l

2.53

Use of pramipexole

178

0.90

0.11

1.5

1.8

3.86

2.38

ug/l

—

Systemic connective tissue disorders

312

0.93

0.11

1.6

1.9

1.55

3.20

ug/l

1.05

180

Cardiodefibrillation

229

0.92

0.11

1.0

1.5

2.25

2.08

ug/l

—

123

Injuries to the elbow and forearm

540

0.95

0.10

1.6

1.9

1.71

2.86

ug/l

1.43

332

Hernia of abdominal wall

342

0.94

0.10

1.8

1.6

1.86

3.03

ug/l

0.63

187

Excessive attrition of teeth

175

0.93

0.10

1.4

2.2

1.30

2.19

ug/l

1.99

111

Perineal laceration during delivery

158

0.90

0.10

1.0

2.1

2.18

4.24

ug/l

—

Parodontitis or/and operation codes

317

1.05

0.10

2.2

1.9

2.38

2.82

ug/l

0.15

188

Falls/tendency to fall

110

569

0.97

0.10

1.8

2.58

3.54

ug/l

0.42

356

Intracranial trauma

408

0.95

0.10

1.6

2.0

1.57

4.02

ug/l

1.17

257

Postpartum hemorraghe, parous women as controls

194

1.08

0.10

2.6

1.7

2.81

3.15

ug/l

0.08

122

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

183

1.09

0.10

1.3

1.9

2.78

2.23

ug/l

0.17

Allergic asthma (mode), excluding more controls

224

0.92

0.10

1.5

2.0

3.18

3.36

ug/l

—

142

Allergic asthma (mode)

224

0.92

0.10

1.5

2.0

3.18

3.39

ug/l

—

141

Heart failure,strict

261

0.94

0.10

1.1

1.6

3.17

2.42

ug/l

0.36

147

Diseases of male genital organs

0.90

0.10

1.0

1.60

2.21

ug/l

—

Other joint disorders

437

0.96

0.10

1.6

2.0

2.28

3.82

ug/l

0.63

281

Other viral diseases

217

0.92

0.09

1.8

1.7

2.66

3.36

ug/l

0.21

125

Spondylosis

358

1.05

0.09

1.5

1.8

2.72

2.99

ug/l

0.09

224

Other functional intestinal disorders

334

0.94

0.09

3.0

1.8

1.76

2.98

ug/l

0.74

196

Aplastic and other anaemias

294

1.06

0.09

1.9

1.7

11.87

2.24

ug/l

0.65

169

Cerebrovascular diseases (FINNGEN)

180

1.07

0.09

2.6

1.8

1.94

2.23

ug/l

0.27

Other and unspecified polyneuropathies, also in other diseases

124

0.89

0.09

2.9

1.6

1.54

2.06

ug/l

—

Other disorders of lacrimal gland

311

1.06

0.09

1.2

1.9

1.86

3.11

ug/l

0.77

186

Leiomyoma of uterus

425

0.96

0.09

1.5

2.1

2.75

4.11

ug/l

0.44

267

Infections with a predominantly sexual mode of transmission

262

1.07

0.09

1.9

1.8

1.68

3.42

ug/l

0.95

157

Injury of muscle and tendon at shoulder and upper arm level

237

0.93

0.09

1.3

1.7

3.41

2.00

ug/l

—

124

Arthropathies

437

0.97

0.09

1.5

2.0

2.46

3.82

ug/l

0.52

281

Delivery

250

0.95

0.08

2.1

2.0

2.63

2.79

ug/l

0.11

156

Thyrotoxicosis, other and/or unspecified

185

0.92

0.08

1.4

1.8

3.39

2.39

ug/l

—

105

Ulcerative colitis

185

1.08

0.08

1.2

1.6

1.16

2.05

ug/l

3.60

Vasomotor rhinitis (mode)

0.77

0.08

1.4

1.8

1.16

1.86

ug/l

—

Acetic acid derivatives and related substances

101

1.08

0.08

1.7

1.9

2.50

2.73

ug/l

—

Tonsillectomy and adenotomy

354

1.04

0.08

2.5

1.8

2.01

4.31

ug/l

0.81

218

Endometriosis of pelvic peritoneum

125

1.11

0.08

2.1

2.5

1.50

2.42

ug/l

—

Female infertility

165

0.94

0.08

1.4

2.3

1.30

2.51

ug/l

3.15

110

Nontoxic multinodular goitre

195

1.08

0.08

3.0

1.8

1.98

2.47

ug/l

0.49

113

Atopic dermatitis

418

1.04

0.07

1.3

2.0

2.75

3.23

ug/l

0.15

252

Asthma and allergy, excluding more controls

121

0.90

0.07

1.4

2.1

3.70

4.29

ug/l

—

Injuries to the shoulder and upper arm

563

0.97

0.07

1.3

1.8

2.51

2.79

ug/l

0.21

335

Spontaneous abortion

367

0.96

0.07

2.0

2.1

1.95

3.56

ug/l

0.65

230

Primary open-angle glaucoma, strict

183

0.93

0.07

1.3

1.6

1.73

2.51

ug/l

—

Depression

622

0.97

0.07

2.3

1.7

2.06

3.56

ug/l

0.97

384

Conjunctivitis (acute, non atopic)

225

1.06

0.06

1.1

1.8

2.84

2.10

ug/l

0.51

122

Congenital malformations of the circulatory system

0.88

0.06

1.1

1.9

1.93

1.89

ug/l

—

Parodontitis

576

0.97

0.06

2.2

1.7

2.51

2.79

ug/l

0.14

343

Coronary revascularization (ANGIO or CABG)

226

1.05

0.06

1.3

1.5

2.36

2.31

ug/l

0.04

126

Single delivery by caesarean section

106

0.93

0.06

1.4

2.3

2.01

2.82

ug/l

—

Glucagon-like peptide-1 (GLP-1) analogues

334

0.96

0.06

1.4

1.7

2.56

2.57

ug/l

0.00

191

Disorders of synovium and tendon

435

1.04

0.06

1.7

1.8

1.83

2.86

ug/l

0.87

271

Benign mammary dysplasia

162

0.93

0.06

1.2

2.0

1.95

2.56

ug/l

—

Diseases of the eye and adnexa

410

1.03

0.06

1.8

2.19

3.89

ug/l

0.66

253

Follow-up examination after treatment for conditions other than malignant neoplasms

245

1.04

0.06

1.4

1.9

1.73

4.44

ug/l

0.84

162

Heart failure and bmi 25plus

161

0.94

0.06

1.0

1.7

3.42

2.17

ug/l

0.39

Malignant neoplasm of breast, HER-positive

360

0.96

0.06

1.2

2.0

18.22

3.21

ug/l

0.43

223

Disorders of vitreous body and globe

425

0.96

0.06

1.8

2.34

2.30

ug/l

0.04

252

Glaucoma

381

1.04

0.05

1.4

1.7

2.18

2.50

ug/l

0.20

222

Enthesopathies of lower limb, excluding foot

182

0.93

0.05

1.8

1.90

3.48

ug/l

0.53

112

Benign neoplasm of breast

131

0.92

0.05

1.2

2.1

1.26

2.07

ug/l

—

Radiculopathy

131

0.92

0.05

1.1

2.0

1.70

2.51

ug/l

—

Fall on same level

107

610

0.98

0.05

1.6

1.8

2.70

3.46

ug/l

0.33

376

Retinal detachments and breaks

253

0.95

0.05

1.6

1.9

2.82

2.43

ug/l

0.14

140

Major coronary heart disease event

358

0.97

0.05

1.4

1.7

2.56

2.55

ug/l

0.01

208

Primary open-angle glaucoma

212

1.06

0.05

1.3

1.6

1.90

2.36

ug/l

0.69

115

Chronic periodontitis, including avohilmo

576

0.98

0.05

2.2

1.7

2.51

2.79

ug/l

0.14

343

Chronic lower respiratory diseases

111

612

0.98

0.05

1.5

1.9

2.36

3.57

ug/l

0.66

373

Personality disorders, excluding more controls

208

1.06

0.05

2.5

1.9

2.68

3.53

ug/l

0.25

130

Hypo-osmolality and hyponatraemia

129

1.08

0.05

1.2

1.5

1.80

2.17

ug/l

—

Recurrent or chronic depression

307

1.04

0.05

2.5

1.8

1.75

4.66

ug/l

1.00

194

Spondylolisthesis/Spondylolysis

161

0.93

0.05

1.9

3.64

2.18

ug/l

—

Anxiety (asthma-related co-morbidities)

446

0.97

0.05

1.6

1.8

1.48

3.82

ug/l

1.22

274

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

526

0.97

0.05

1.9

2.52

3.56

ug/l

0.44

329

Constipation

546

1.02

0.05

2.0

1.8

2.31

2.76

ug/l

0.33

328

Conjunctivitis

613

1.02

0.04

1.7

1.9

2.73

3.50

ug/l

0.35

376

Other diseases of liver

130

0.92

0.04

1.3

1.8

1.50

2.10

ug/l

—

Female infertility, cervigal, vaginal, other or unspecified origin

162

0.95

0.04

1.5

2.3

1.33

2.53

ug/l

2.81

108

Dental pulpitis 2, only avohilmo

341

0.98

0.04

1.3

1.9

1.46

2.64

ug/l

4.00

198

Other neurological diseases

454

0.97

0.04

1.2

1.7

2.63

3.00

ug/l

0.15

267

Supervision of high-risk pregnancy

132

1.05

0.04

1.1

2.3

1.71

4.47

ug/l

0.85

All anxiety disorders

439

1.03

0.04

1.6

1.8

1.50

4.00

ug/l

1.27

264

Atrial fibrillation and flutter

162

1.05

0.04

2.3

1.8

1.66

2.31

ug/l

0.88

Concussion

395

1.03

0.04

1.7

1.9

1.60

2.90

ug/l

1.15

246

Asthma and allergy

118

0.92

0.04

1.4

2.1

3.70

4.32

ug/l

—

Abnormalities of heart beat

309

0.96

0.04

2.7

1.8

2.81

3.17

ug/l

0.12

190

Benign neoplasm: Colon, unspecified

170

0.94

0.04

1.2

1.7

1.51

2.13

ug/l

1.10

Polyarthropathies

396

0.98

0.04

1.6

2.0

2.06

3.98

ug/l

0.81

257

Other disorders of the musculoskeletal system and connective tissue

111

1.08

0.04

1.7

1.6

4.71

1.97

ug/l

—

Leisure time condition

129

0.93

0.03

1.2

1.8

1.70

2.08

ug/l

—

Hallux rigidus

131

1.07

0.03

1.5

2.2

1.90

2.05

ug/l

—

Pre-eclampsia

220

0.95

0.03

1.3

2.1

1.45

3.64

ug/l

1.02

129

Coxibs

101

1.05

0.03

1.2

1.9

1.37

2.73

ug/l

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

230

0.96

0.03

1.2

1.8

2.52

2.29

ug/l

0.08

123

Fracture at wrist and hand level

250

0.96

0.03

1.8

1.7

1.72

2.23

ug/l

0.92

131

Other/unspecified seropositive rheumatoid arthritis

240

0.96

0.03

1.3

1.9

5.74

2.39

ug/l

0.59

137

Rheumatoid arthritis

264

0.96

0.03

1.3

2.0

4.79

3.02

ug/l

0.32

163

Gingivitis and periodontal diseases

441

0.98

0.03

1.3

1.8

2.20

3.57

ug/l

0.55

271

5-aminosalicylic acid

161

1.06

0.03

1.1

1.7

1.16

2.14

ug/l

—

Bleeding

478

1.02

0.03

1.8

1.7

2.03

3.10

ug/l

0.97

280

Allergic conjunctivitis

543

0.98

0.03

1.9

2.74

3.48

ug/l

0.29

342

Conductive and sensorineural hearing loss

462

1.02

0.03

2.1

1.7

1.79

3.00

ug/l

1.12

268

Nutritional anaemias

370

0.97

0.03

1.7

1.8

9.17

2.36

ug/l

0.44

216

Disorders of ocular muscles, binocular movement, accommodation and refraction

377

0.97

0.03

1.7

1.9

2.99

2.95

ug/l

0.01

225

Hernia

561

1.02

0.03

1.4

1.8

2.06

2.81

ug/l

0.68

344

Gastroduodenal ulcer

171

1.05

0.02

1.2

1.7

1.90

2.24

ug/l

—

Other arrhythmias

443

1.02

0.02

1.8

1.9

1.86

3.05

ug/l

1.12

271

Dental pulpitis 2

339

0.98

0.02

1.3

1.9

1.46

2.64

ug/l

4.02

197

Other disorders of veins

340

1.03

0.02

1.3

1.9

3.93

2.92

ug/l

0.27

203

Chronic sinusitis

380

1.03

0.02

1.3

1.9

2.13

4.16

ug/l

0.74

237

Hyperlipidaemia, other/unspecified

245

0.97

0.02

1.4

3.15

2.29

ug/l

0.49

130

Spondylopathies

406

1.02

0.02

1.6

1.8

2.20

2.87

ug/l

0.39

251

Pain in throat and chest

490

0.99

0.02

1.6

1.8

1.83

3.86

ug/l

1.10

305

Keratitis

289

0.97

0.02

1.7

1.8

4.71

3.19

ug/l

0.29

159

L02BG Aromatase inhibitors

299

0.97

0.02

1.3

2.0

1.85

2.40

ug/l

0.60

184

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

301

1.03

0.02

1.5

1.9

2.82

3.25

ug/l

0.12

174

Asthma (only as main-diagnosis)

429

0.98

0.02

1.3

1.8

2.40

4.06

ug/l

0.64

266

Parodontitis or operation codes

575

0.99

0.02

2.2

1.7

2.51

2.79

ug/l

0.14

343

Pregnancy with abortive outcome

419

0.99

0.02

1.6

2.0

5.54

3.58

ug/l

0.23

266

Asthma, hospital admissions , main diagnosis only

645

0.99

0.02

1.4

1.9

2.43

3.44

ug/l

0.50

396

Diseases of the ear and mastoid process

114

583

0.99

0.02

2.3

1.7

6.42

2.79

ug/l

0.43

348

Emergency coronary revascularization (for ACS)

245

1.03

0.02

1.3

1.5

2.27

2.37

ug/l

0.08

138

Soft tissue disorders related to use, overuse and pressure

218

0.96

0.02

1.3

1.7

2.65

2.20

ug/l

0.13

129

Other headache syndromes

431

1.02

0.02

1.5

2.0

2.42

3.85

ug/l

0.52

267

Other and unspecified effects of external causes

222

1.04

0.02

1.5

1.8

2.11

3.42

ug/l

0.48

127

Thyrotoxicosis

238

0.97

0.02

2.2

1.9

2.75

3.53

ug/l

0.16

136

Other and unspecified anaemias

269

0.97

0.02

1.7

14.02

2.35

ug/l

0.63

151

Coronary artery bypass grafting

116

1.05

0.02

1.1

1.4

2.36

2.21

ug/l

—

Panic disorder

123

1.06

0.01

1.3

1.7

1.26

2.02

ug/l

—

Generalized anxiety disorder

123

1.06

0.01

1.2

1.8

1.05

2.00

ug/l

—

Migraine with aura and triptan purchases

143

1.05

0.01

1.2

2.0

1.36

4.03

ug/l

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

147

0.95

0.01

2.4

1.5

1.99

2.26

ug/l

—

Medicines for HER+ breast cancer

368

0.98

0.01

1.2

2.0

17.38

3.20

ug/l

0.43

226

Umbilical hernia

173

1.04

0.01

2.4

1.5

1.45

1.99

ug/l

0.83

Other disorders of eyelid

355

0.98

0.01

2.0

1.8

2.64

2.44

ug/l

0.08

210

Functional dyspepsia

237

0.97

0.01

1.2

1.8

1.59

3.47

ug/l

0.91

139

Injuries to the abdomen, lower back, lumbar spine and pelvis

295

0.98

0.01

2.7

1.7

3.38

3.25

ug/l

0.03

166

Sensorineural hearing loss

443

1.01

0.00

2.2

1.7

1.81

3.02

ug/l

1.08

258

Aneurysms, operations, SAH

126

0.95

0.00

3.5

1.9

1.30

2.39

ug/l

—

Disorders of lipoprotein metabolism and other lipidaemias

423

1.01

0.00

1.6

2.18

2.83

ug/l

0.41

238

Fracture of skull and facial bones

146

0.96

0.00

1.3

1.7

1.67

1.93

ug/l

—

Postpartum hemorraghe, all women as controls

245

0.98

0.00

2.6

1.9

2.81

3.31

ug/l

0.13

153

Intracranial injury

419

1.01

0.00

1.8

1.50

3.00

ug/l

1.51

251

Unspecified haematuria

226

1.02

0.00

1.3

1.6

2.31

2.35

ug/l

0.02

116

Disturbances of skin sensation

224

1.03

0.00

1.0

2.0

1.90

3.66

ug/l

0.74

130

Dental caries 1, only avohilmo

380

1.01

0.00

1.3

1.8

1.64

2.59

ug/l

2.85

224

Care involving use of rehabilitation procedures

452

0.99

0.00

2.1

1.6

2.59

2.73

ug/l

0.05

261

Other nutritional deficiencies

553

0.99

0.00

1.6

1.9

1.94

3.56

ug/l

0.90

332

Single spontaneous delivery

248

0.99

0.00

2.9

2.0

2.57

2.71

ug/l

0.10

155

Asthma (only as main-diagnosis), excluding more controls

417

1.00

0.00

1.3

1.8

2.40

4.04

ug/l

0.61

258

Unstable angina pectoris

207

1.00

0.00

1.0

1.6

2.22

2.31

ug/l

0.05

115

Dental caries 1

370

0.99

0.00

1.3

1.8

1.66

2.60

ug/l

2.74

218

Temporomandibular joint disorders, including avohilmo

380

1.00

0.00

1.1

2.1

1.50

2.99

ug/l

1.31

228

Dental caries, including avohilmo

370

0.99

0.00

1.3

1.8

1.66

2.60

ug/l

2.74

218

Depression or dysthymia

401

1.00

0.00

2.2

1.6

1.61

4.38

ug/l

1.39

253

Injuries to the neck

173

0.98

0.00

1.6

1.7

1.97

2.04

ug/l

—

Other strabismus

171

0.99

0.00

1.8

1.7

4.44

2.16

ug/l

—

Lyme disease

203

0.99

0.00

1.7

2.0

4.98

2.23

ug/l

0.56

106

Other spirochaetal diseases

203

0.99

0.00

1.7

2.0

4.98

2.23

ug/l

0.56

106

Deviated nasal septum

219

1.00

0.00

1.9

1.7

3.81

2.13

ug/l

—

123

STROKE

364

1.01

0.00

1.8

1.7

2.15

3.09

ug/l

0.55

210

Pacemaker

185

1.00

0.00

1.0

1.6

2.33

2.26

ug/l

0.04

101

Fissure and fistula of anal and rectal regions

176

1.02

0.00

1.1

1.8

2.21

2.16

ug/l

—

Meniscus derangement

324

0.99

0.00

1.4

2.0

2.61

2.90

ug/l

0.12

201

Haemorrhage from respiratory passages

225

0.99

0.00

2.1

1.8

2.19

2.36

ug/l

0.13

127

Abnormalities of breathing

511

1.00

0.00

1.7

1.8

2.35

3.79

ug/l

0.67

319

Dental pulpitis 1

102

528

1.00

0.00

1.8

4.59

3.37

ug/l

0.18

308

Undetermined asthma

110

1.00

0.00

1.4

1.9

1.76

2.41

ug/l

—

Seropositive rheumatoid arthritis, strict definition

135

0.96

0.00

1.2

2.1

7.14

2.39

ug/l

—

Ventral hernia

185

0.97

0.00

1.1

1.8

2.26

2.40

ug/l

—

101

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

235

0.98

0.00

1.3

1.9

5.74

2.37

ug/l

0.59

134

Diaphragmatic hernia

298

1.01

0.00

1.2

1.8

1.66

2.35

ug/l

1.14

176

Other anaemias

271

1.00

0.00

1.7

13.46

2.34

ug/l

0.64

152

Suppurative and unspecified otitis media

249

1.00

0.00

2.0

1.8

2.45

3.33

ug/l

0.33

145

Nausea and vomiting

189

0.99

0.00

3.4

1.6

1.79

3.92

ug/l

0.81

116

Benign neoplasm: Sigmoid colon

126

1.03

0.00

1.5

1.8

1.93

2.08

ug/l

—

Preparation and fitting of bite rail to mouth

107

1.03

0.00

1.8

1.08

2.11

ug/l

—

Lateral epicondylitis

117

1.03

0.00

1.0

1.9

3.13

2.43

ug/l

—

Inflammatory disease of uterus

137

1.02

0.00

1.3

1.9

2.26

4.39

ug/l

—

Abnormal serum enzyme levels

134

1.03

0.00

1.0

1.4

1.75

1.76

ug/l

—

Migraine with aura

237

1.01

0.00

1.3

2.1

1.32

3.36

ug/l

1.10

142

Dental pulpitis 4

102

528

1.00

0.00

1.8

4.59

3.37

ug/l

0.18

308

Diseases of pulp and periapical tissues, including avohilmo

102

528

1.00

0.00

1.8

4.59

3.37

ug/l

0.18

308

Urticaria and erythema

324

0.99

0.00

1.3

2.0

3.49

3.11

ug/l

0.11

192

Personality disorders

218

1.01

0.00

2.5

1.7

2.68

3.36

ug/l

0.19

125

Seropositive rheumatoid arthritis, wide

242

0.99

0.00

1.3

1.9

5.45

2.39

ug/l

0.59

137

Pregnancy examination and test

104

1.02

0.00

1.5

2.2

2.73

5.01

ug/l

0.43

Undetermined asthma, excluding more controls

108

1.02

0.00

1.4

1.9

1.76

2.62

ug/l

—

Nontoxic goitre/thyroid nodule

293

0.99

0.00

2.5

1.8

3.12

3.17

ug/l

0.01

172

Chronic gastritis

219

1.00

0.00

1.5

1.9

1.81

2.51

ug/l

0.78

130

Retention of urine

170

0.99

0.00

2.3

1.6

1.34

2.05

ug/l

1.68

Supervision of normal pregnancy

134

0.98

0.00

2.5

2.3

2.10

4.27

ug/l

0.59

Atopic dermatitis, strict definition

230

0.98

0.00

1.5

1.9

2.84

3.51

ug/l

0.17

136

Primary gonarthrosis, bilateral

346

1.01

0.00

1.6

1.8

2.62

2.41

ug/l

0.12

211

Primary coxarthrosis, bilateral

209

1.00

0.00

1.5

1.6

2.73

2.52

ug/l

—

117

Colonic or urogenital fistula

201

1.00

0.00

1.1

1.8

2.04

2.26

ug/l

—

109

Other diseases of pleura

254

1.01

0.00

1.7

1.6

4.31

2.19

ug/l

0.74

138

Fenamates

0.97

0.00

1.4

2.0

1.76

2.66

ug/l

—

Seropositive rheumatoid arthritis

237

1.01

0.00

1.3

1.8

5.45

2.32

ug/l

0.60

140

Other obstetric trauma

0.91

0.00

1.0

1.9

1.82

2.38

ug/l

—

Ankylosing spondylitis

0.95

0.00

1.3

2.2

1.57

1.88

ug/l

—

Ankylosing spondylitis, ICD10

1.00

0.00

1.3

1.9

1.57

1.63

ug/l

—

Other specified and unspecified personality disorders

1.00

0.00

2.1

1.9

3.04

1.66

ug/l

—

Superficial injury of thorax

100

1.00

0.00

2.6

1.7

7.72

1.98

ug/l

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS